name: Staphylococcus lugdunensis DNA:PrThr:Pt:Body fld:Ord:Non-probe.amp.tar


name: Stenotrophomonas maltophilia DNA:PrThr:Pt:Body fld:Ord:Non-probe.amp.tar


name: Streptococcus pneumoniae DNA:PrThr:Pt:Body fld:Ord:Non-probe.amp.tar


name: Streptococcus pyogenes DNA:PrThr:Pt:Body fld:Ord:Non-probe.amp.tar


name: Streptococcus sp DNA:PrThr:Pt:Body fld:Ord:Non-probe.amp.tar


name: Staphylococcus sp DNA:PrThr:Pt:Body fld:Ord:Non-probe.amp.tar


name: Salmonella sp DNA:PrThr:Pt:Body fld:Ord:Non-probe.amp.tar


name: Acinetobacter calcoaceticus-baumannii complex DNA:PrThr:Pt:Body fld:Ord:Non-probe.amp.tar


name: Infectious pathogens panel:-:Pt:Body fld:-:Non-probe.amp.tar


name: SARS-CoV-2 ORF1ab + N gene:PrThr:Pt:Nph:Ord:Probe.amp.tar


name: Deprecated Influenza virus B NS gene [Presence] in Nasopharynx by NAA with probe detection


name: Respiratory syncytial virus N gene:PrThr:Pt:Nph:Ord:Probe.amp.tar


name: Coagulation factor VIII activity actual/Normal:RelACnc:Pt:PPP:Qn:Bovine factor X substrate + Chromogenic


name: Parainfluenza virus 1+2+3+4 Ab.IgG:ACnc:Pt:Ser:Qn:IA


name: Month of first prenatal care visit:Time:Pt:^Patient:Qn


name: Tissue perfusion and oxygenation:Find:Pt:^Patient:Ord


name: Free from harm related to unintentional contamination of the sterile field and wound:Find:Pt:^Patient:Ord


name: Natriuretic peptide.B prohormone N-Terminal:MCnc:Pt:Ser/Plas/Bld:Qn:IA.rapid


name: Bacillus anthracis lethal factor Ab:PrThr:Pt:Ser:Ord:IA


name: HIV pre exposure prophylaxis monitoring panel:-:Pt:Ser/Plas:-


name: HIV pre exposure prophylaxis monitoring panel


name: Respiratory syncytial virus A+B N gene:PrThr:Pt:Nph:Ord:Probe.amp.tar


name: Hereditary thyroid cancer multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Hereditary thyroid cancer multigene analysis


name: Hereditary renal cancer multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Hereditary renal cancer multigene analysis


name: Hereditary pancreatic cancer multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Hereditary pancreatic cancer multigene analysis


name: Myelodysplastic neoplasm chromosome analysis:Find:Pt:Bld/Bone mar:Doc:FISH


name: Myelodysplastic neoplasm chromosome analysis


name: Membranous nephropathy associated antigens analysis:Find:Pt:Tiss:Doc:LC/MS/MS


name: Membranous nephropathy associated antigens analysis


name: Contactin-associated protein 1 Ab:PrThr:Pt:Ser:Ord:CBA IFA


name: LDL receptor related protein 4 Ab:PrThr:Pt:Ser:Ord:CBA IFA


name: Where was the pregnancy followed-up:Type:Pt:^Patient:Nom


name: Hours before delivery when membranes ruptured:Time:Pt:^Patient:Qn


name: Hours before delivery when membranes ruptured


name: Analytical tests in the third trimester of pregnancy:Find:Pt:^Patient:Ord


name: Analytical tests in the third trimester of pregnancy


name: Continuous glucose monitoring time in ranges panel:-:Pt:^Patient:-


name: Continuous glucose monitoring time in ranges panel


name: Peanut components allergen IgE panel:-:Pt:Ser:-:IA


name: Total Score:Score:Pt:^Animal:Qn:Feline grimace scale


name: Feline Grimace Scale Panel:-:Pt:^Animal:-:Feline grimace scale


name: Pupillary response:Find:Pt:Eye:Nom:Swinging light test


name: Coagulation factor XIII inhibitor:ACnc:Pt:PPP:Qn:Chromo


name: Cytomegalovirus UL56 gene mutations detected:Prid:Pt:Isolate:Nom


name: Cytomegalovirus UL56 gene mutations detected


name: Arachis hypogaea recombinant Ab.IgE & IgD & IgG4 & IgA:Type:Pt:Ser/Plas:Ord:IA


name: PROMIS Item Bank v1.0 - Emotional Distress - Anxiety - Short Form 8a:-:Pt:^Patient:-:PROMIS


name: PROMIS Item Bank v1.0 - Emotional Distress - Anxiety - Short Form 8a


name: HIV1+2 Ab & Treponema pallidum Ab:PrThr:Pt:Ser/Plas/Bld:Ord:IA.rapid


name: Relapse after end of treatment:Imp:Pt:^Patient:Nar


name: How often have you found yourself thinking about things that you have to accomplish:Find:1Mo:^Patient:Ord


name: How often have you found yourself thinking about things that you have to accomplish


name: How often have you been able to control the way you spend your time:Find:1Mo:^Patient:Ord


name: How often have you been able to control the way you spend your time


name: How often have you felt that you were effectively coping with important changes that were occurring in your life:Find:1Mo:^Patient:Ord


name: How often have you felt that you were effectively coping with important changes that were occurring in your life


name: How often have you dealt successfully with day to day problems and annoyances:Find:1Mo:^Patient:Ord


name: How often have you dealt successfully with day to day problems and annoyances


name: Gram negative bacteria DNA:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Colony forming unit granulocyte macrophage:NCnt:Pt:Bld:Qn


name: Colony forming unit granulocyte macrophage:NCnc:Pt:Hematopoietic progenitor cells^BPU:Qn


name: Colony forming unit granulocyte macrophage:NCnc:Pt:Bld:Qn:VC


name: Social or personal history:Find:Pt:^Patient:Nom


name: Did a current or former partner make you feel afraid that they might try to hurt you in some way:Find:1Y:^Patient:Ord


name: Did a current or former partner make you feel afraid that they might try to hurt you in some way


name: Did a current or former partner make you feel cut off from others, trapped, or controlled in a way you did not like:Find:1Y:^Patient:Ord


name: Did a current or former partner make you feel cut off from others, trapped, or controlled in a way you did not like


name: Intimate Partner Violence 4:-:RptPeriod:^Patient:-:IPV-4


name: Did a current or former partner pressure or force you to do something sexual that you didn't want to do:Find:1Y:^Patient:Ord


name: Did a current or former partner pressure or force you to do something sexual that you didn't want to do


name: Did a current or former partner hit, kick, punch, slap, shove, or otherwise physically hurt you:Find:1Y:^Patient:Ord


name: Did a current or former partner hit, kick, punch, slap, shove, or otherwise physically hurt you


name: Hepatitis D virus Ab:PrThr:Pt:Ser/Plas:Ord:IA


name: Hepatitis B virus core Ab:ACnc:Pt:Ser/Plas:Qn:IA


name: Amyloid plaques probability score:Score:Pt:Plas:Nom:Calculation


name: Tau protein.phosphorylated 217/Tau protein.unphosphorylated 217:MRto:Pt:Plas:Qn:LC/MS/MS


name: Amyloid beta 42 peptide/Amyloid beta 40 peptide:MRto:Pt:Plas:Qn:LC/MS/MS


name: Human urine markers assessment:PrThr:Pt:Urine:Ord:Confirm


name: pH^^adjusted to eucapnic level:LsCnc:Pt:BldCoA:SemiQn:Calculated


name: Testis expressed Protein 101:MCnc:Pt:Semen:Qn:IA


name: Extracellular Matrix Protein 1:MCnc:Pt:Semen:Qn:IA


name: Medical device description panel:-:Pt:^Patient:-


name: Body mass index formula:Find:Pt:^Patient:Nar


name: PROMIS Pediatric Item Bank GenPop v3.0 - Depressive Symptoms - Short Form 8a:-:Pt:^Patient:-:PROMIS


name: PROMIS Pediatric Item Bank GenPop v3.0 - Depressive Symptoms - Short Form 8a


name: PROMIS pediatric depressive symptoms - version 3.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS.PEDS


name: PROMIS pediatric depressive symptoms - version 3.0 T-score


name: PROMIS Pediatric Item Bank GenPop v3.0 - Depressive Symptoms - Short Form 8a raw score:Score:Pt:^Patient:Qn:PROMIS.PEDS


name: PROMIS Pediatric Item Bank GenPop v3.0 - Depressive Symptoms - Short Form 8a raw score


name: Oxygen delivery additional details:Find:Pt:^Patient:Nar


name: Method of oxygen delivery:Find:Pt:^Patient:Nom


name: Waveform observation information panel:-:Pt:^Patient:-


name: SpO2 waveform sample period:Time:Pt:^Patient:Qn


name: SpO2 waveform scaling factor:Num:Pt:^Patient:Qn


name: Level of exertion information panel:-:Pt:^Patient:-


name: Medication dispense directions information panel:-:Pt:Medication:-


name: Medication dispense directions information panel


name: Multimedia object create date:Date:Pt:^Patient:Qn


name: General structured lab report:-:Pt:^Patient:-


name: Day of menstrual cycle:Find:Pt:^Patient:Ord


name: SpO2 preductal or postductal indicator:Find:Pt:^Patient:Nom


name: Mean arterial pressure formula:Find:Pt:^Patient:Nar


name: Medication safety information panel:-:Pt:Medication:-


name: Medication total daily effective dose purpose:Find:Pt:Medication:Nar


name: Medication total daily effective dose purpose


name: Inspired oxygen information panel:-:Pt:^Patient:-


name: Viable CD3 cells/Cells.CD3:NFr:Pt:Hematopoietic progenitor cells^BPU:Qn


name: Viable CD45 cells/Cells.CD45:NFr:Pt:Hematopoietic progenitor cells^BPU:Qn


name: CD45 dose:NCnt:Pt:Hematopoietic progenitor cells^BPU:Qn


name: Congenital heart disease screening:Find:Pt:^Newborn:Ord


name: Hyaline casts:NCnc:Pt:Urine sed:Qn:Automated count


name: Granular casts:NCnc:Pt:Urine sed:Qn:Computer assisted


name: Erythrocyte casts:NCnc:Pt:Urine sed:Qn:Computer assisted


name: Leukocyte casts:NCnc:Pt:Urine sed:Qn:Computer assisted


name: Legionella sp:Prid:Pt:Asp:Nom:Organism specific culture


name: Mycobacterium sp:Prid:Pt:Skin:Nom:Organism specific culture


name: Mycobacterium sp:Prid:Pt:Semen:Nom:Organism specific culture


name: Mycobacterium sp:Prid:Pt:Drain:Nom:Organism specific culture


name: Mycobacterium sp:Prid:Pt:Abscess:Nom:Organism specific culture


name: Mycobacterium sp:Prid:Pt:Amnio fld:Nom:Organism specific culture


name: Natriuretic peptide.B prohormone N-Terminal:MCnc:Pt:Body fld:Qn:IA


name: Casts type not specified:PrThr:Pt:Urine sed:Ord:Computer assisted


name: Platelets^in presence of EDTA to detect possible clumping:NCnc:Pt:Bld:Qn:Automated count


name: IgK gene Tube B length in base pairs:Num:Pt:XXX:Qn:Molgen


name: IgK gene Tube A length in base pairs:Num:Pt:XXX:Qn:Molgen


name: IgH FR3 length in base pairs:Num:Pt:XXX:Qn:Molgen


name: IgH FR2 length in base pairs:Num:Pt:XXX:Qn:Molgen


name: IgH FR1 length in base pairs:Num:Pt:XXX:Qn:Molgen


name: TCRB gene Tube C length in base pairs:Num:Pt:XXX:Qn:Molgen


name: TCRB gene Tube B length in base pairs:Num:Pt:XXX:Qn:Molgen


name: TCRB gene Tube A length in base pairs:Num:Pt:XXX:Qn:Molgen


name: TCRG gene Tube B length in base pairs:Num:Pt:XXX:Qn:Molgen


name: TCRG gene Tube A length in base pairs:Num:Pt:XXX:Qn:Molgen


name: Treponema pallidum Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Octamer binding transcription factor 3+4 Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: NKX3.1 homeodomain transcription factor Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Microphthalmia-associated transcription factor 1 Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: GATA binding protein 3 Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: FLI-1 Oncoprotein Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: c-MYC Oncoprotein Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Amyloid Beta Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Natriuretic peptide.B^^adjusted for eGFR:MCnc:Pt:Ser/Plas:Qn


name: Sjogrens syndrome-A extractable nuclear 60kD Ab.IgG:ACnc:Pt:Ser:Qn:IA


name: 1p & 19q chromosome deletion:Find:Pt:Tiss:Doc:FISH


name: Clonality analysis of Ig receptor genes:Find:Pt:XXX:Doc:Sequencing


name: Measurable residual disease analysis:Find:Pt:XXX:Ord:Sequencing


name: Tick borne encephalitis virus Ab:Imp:Pt:Ser/Plas:Nom


name: Rh antigens C little c E little e panel:-:Pt:RBC:-


name: Busulfan^5H post busulfan infusion completion:MCnc:Pt:Plas:Qn


name: Busulfan^3H post busulfan infusion completion:MCnc:Pt:Plas:Qn


name: Busulfan^15M post busulfan infusion completion:MCnc:Pt:Plas:Qn


name: Total number of doses:Num:Pt:^Patient:Qn


name: Test dose included in cumulative AUC:Find:Pt:^Patient:Ord


name: NUP98 11p15.4 gene rearrangement:Prid:Pt:Bld/Tiss:Nom:FISH


name: ASXL1 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Sequencing


name: CSF3R gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Sequencing


name: CBL gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Sequencing


name: CALR gene exon 9 targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Sequencing


name: MPL gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Sequencing


name: PDGFRA gene full mutation analysis:PrThr:Pt:Bld/Tiss:Ord:Sequencing


name: Guidance for percutaneous mechanical thrombectomy:Find:Pt:Chest>Pulmonary arteries.right:Doc:RF


name: Guidance for percutaneous mechanical thrombectomy


name: Guidance for percutaneous mechanical thrombectomy:Find:Pt:Chest>Pulmonary artery:Doc:RF


name: Guidance for percutaneous aspiration thrombectomy:Find:Pt:Lower extremity.left>Lower extremity artery:Doc:RF


name: Guidance for percutaneous aspiration thrombectomy


name: Guidance for embolization:Find:Pt:Head+Neck>Carotid arteries.left:Doc:RF


name: Guidance for embolization:Find:Pt:Head>Cerebral artery:Doc:RF.angio


name: Guidance for insertion of stent:Find:Pt:Head+Neck>Carotid arteries.right:Doc:RF.angio


name: Views:Find:Pt:Upper extremity.right>Wrist:Doc:XR && RF


name: Views:Find:Pt:Upper extremity.left>Wrist:Doc:XR && RF


name: Guidance for reposition of central venous catheter:Find:Pt:XXX:Doc:RF


name: Guidance for exchange of central venous catheter:Find:Pt:XXX:Doc:RF


name: Guidance for exchange of central venous catheter


name: Views:Find:Pt:Upper extremity.right:Doc:XR && RF


name: Views:Find:Pt:Upper extremity.left:Doc:XR && RF


name: Views:Find:Pt:Upper extremity.bilateral:Doc:XR && RF


name: Infusion start date and time:TmStp:Pt:^Patient:Qn


name: Infusion stop date and time:TmStp:Pt:^Patient:Qn


name: Busulfan area under the curve:TmMCnc:Stdy:Plas:Qn


name: Busulfan area under the curve.cumulative:TmMCnc:Stdy:Plas:Qn


name: Busulfan area under the curve.cumulative


name: Homologous recombination deficiency status analysis:Threshold:Pt:Tiss:Ord:Molgen


name: Homologous recombination deficiency status analysis


name: Candida species DNA panel:-:Pt:Bld:-:Probe.amp.tar


name: Guidance for embolization:Find:Pt:Chest>Pulmonary artery:Doc:RF


name: Guidance for radiofrequency ablation:Find:Pt:Chest>Spine.thoracic intercostal nerve:Doc:RF


name: Guidance for replacement of gastrojejunostomy tube:Find:Pt:Abdomen>Gastrointestinal tract.upper:Doc:RF


name: Guidance for replacement of gastrojejunostomy tube


name: Guidance for placement of stent graft:Find:Pt:Neck>Carotid artery.common.right:Doc:RF.angio


name: Guidance for placement of gastrojejunostomy tube:Find:Pt:Abdomen>Gastrointestinal tract.upper:Doc:RF


name: Guidance for embolization:Find:Pt:Head+Neck>Carotid artery.external:Doc:RF


name: Guidance for percutaneous transluminal angioplasty:Find:Pt:Abdomen+Pelvis>Iliac artery:Doc:RF


name: Guidance for percutaneous thrombectomy:Find:Pt:Head>Cerebral artery:Doc:RF


name: Caregiver follow-up goal attainment scaling score:Score:Pt:^Patient:Ord


name: Caregiver follow-up goal attainment scaling score


name: Goal attainment scale GAS follow-up assessment:-:Pt:^Patient:-:Reported


name: Goal attainment scale GAS follow-up assessment


name: Practitioner follow-up goal attainment scaling score:Score:Pt:^Patient:Ord


name: Practitioner follow-up goal attainment scaling score


name: Patient follow-up goal attainment scaling score:Score:Pt:^Patient:Ord


name: Patient follow-up goal attainment scaling score


name: PROMIS emotional distress anxiety version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS emotional distress anxiety version 1.0 raw score


name: Breast cancer molecular subtype:Find:Pt:Tiss:Nom:Prosigna


name: Influenza virus A+B RNA:PrThr:Pt:Nph:Ord:Probe.amp.tar


name: Herpes virus 7 DNA:PrThr:Pt:CSF:Ord:Probe.amp.tar


name: Herpes virus 6 DNA:PrThr:Pt:Ser/Plas:Ord:Probe.amp.tar


name: Microscopic observation:Prid:Pt:Stool:Nom:Acid fast stain.Kinyoun modified


name: Influenza virus B RNA:PrThr:Pt:Sputum:Ord:Non-probe.amp.tar


name: Influenza virus A RNA:PrThr:Pt:Sputum:Ord:Non-probe.amp.tar


name: Human papilloma virus genotype:Prid:Pt:Semen:Nom:Probe.amp.tar


name: Common myeloid progenitor cell:Naric:Pt:Plas:Qn


name: von Willebrand factor activity.glycoprotein Ib gain of function (GPIbM) actual/Normal:RelRto:Pt:PPP:Qn:Turbidimetry


name: von Willebrand factor activity.glycoprotein Ib gain of function (GPIbM)von Willebrand factor activity.glycoprotein Ib gain of function (GPIbM)


name: von Willebrand factor activity.ristocetin cofactor (GPIbR) actual/Normal:RelRto:Pt:PPP:Qn:Turbidimetry


name: von Willebrand factor activity.ristocetin cofactor (GPIbR) actual/Normal


name: Ciliated columnar lining cells/Leukocytes


name: Spermatozoa.tail tip.motile with IgA/Spermatozoa


name: Spermatozoa.tail tip.motile with IgG/Spermatozoa


name: Spermatozoa.tail tip.motile with IgM/Spermatozoa


name: Cells.aneuploid.G2 phase population 2/Cells


name: Cells.aneuploid.S phase population 2/Cells


name: Cells.programmed cell death ligand 1/Viable tumor cells


name: Cells.HER2 uniform intense membrane staining/Cells


name: Cells.CD8.PMA+ionomycin stimulated CD107a+b expressing/Cells.CD3+CD8+


name: Cells.CD8.PMA+ionomycin stimulated gamma interferon producing/Cells.CD3+CD8+


name: Monocytes.programmed cell death ligand 1/Monocytes


name: in presence of EDTA to detect possible clumping


name: How often have you been upset because of something that happened unexpectedly


name: How often have you felt that you were unable to control the important things in your life


name: Did problems with transportation affect your relationships with others


name: Busulfan^15M post busulfan infusion completion


name: Busulfan^3H post busulfan infusion completion


name: Busulfan^5H post busulfan infusion completion


name: Yeast colony^with canavanine glycine+bromothymol blue


name: Yeast colony^with Sabouraud Dextrose Agar


name: Tau protein.phosphorylated 217/Tau protein.unphosphorylated 217


name: How often have you felt nervous and stressed


name: How often have you felt confident about your ability to handle your personal problems


name: How often have you felt that things were going your way


name: How often have you found that you could not cope with all the things that you had to do


name: How often have you been able to control irritations in your life


name: How often have you felt that you were on top of things


name: How often have you felt difficulties were piling up so high that you could not overcome them


name: Blood group antibody^post transfusion reaction


name: Campylobacter & Salmonella & Shigella sp^^^2


name: Campylobacter & Salmonella & Shigella sp^^^3


name: Cells.recipient derived/Cells^post stem cell transplantation


name: Spermatozoa.slow/Spermatozoa ^1H post ejaculation


name: Has the electric, gas, oil, or water company threatened to shut off services in your home


name: Platelets^in presence of EDTA to detect possible clumping


name: von Willebrand factor activity.glycoprotein Ib


name: von Willebrand factor activity.ristocetin cofactor (GPIbR)


name: Creatinine, Cystatin C and Urea-based formula (CKiD)/1.73 sq M


name: Creatinine-based formula (MDRD)/1.73 sq M


name: Creatinine-based formula (Schwartz)/1.73 sq M


name: Creatinine-based formula (CKD-EPI)/1.73 sq M


name: Creatinine and Cystatin C-based formula (CKD-EPI)/1.73 sq M


name: Creatinine-based formula (CKD-EPI 2021)/1.73 sq M


name: Creatinine and Cystatin C-based formula (CKD-EPI 2021)/1.73 sq M


name: Creatinine-based formula (MDRD)/1.73 sq M among black population


name: Creatinine-based formula (CKD-EPI)/1.73 sq M among black population


name: based on 1.73 sq M among black population


name: Creatinine-based formula (MDRD)/1.73 sq M among female population


name: Creatinine-based formula (MDRD)/1.73 sq M among male population


name: Creatinine-based formula (MDRD)/1.73 sq M among non black population


name: Creatinine-based formula (CKD-EPI)/1.73 sq M among non black population


name: based on 1.73 sq M among non black population


name: Fungus and Mycobacterium sp | Blood | Microbiology


name: Observation | Sputum tracheal aspirate | Microbiology


name: Colony count | Bronchoalveolar lavage | Microbiology


name: Colony count | Sputum tracheal aspirate | Microbiology


name: Microorganism or agent | XXX | Microbiology


name: Mycobacterium preliminary growth | Bronchoalveolar lavage | Microbiology


name: Mycobacterium preliminary growth | Cerebral spinal fluid | Microbiology


name: Mycobacterium preliminary growth | Pleural fluid | Microbiology


name: Mycobacterium preliminary growth | XXX | Microbiology


name: cefTAZidime+cloxacillin | Isolate | Antibiotic susceptibilities


name: OXA-40 and OXA-58 carbapenemase | Isolate or Specimen | Antibiotic susceptibilities


name: Beta lactamase.AmpC type | Isolate | Antibiotic susceptibilities


name: Rezafungin | Isolate | Antibiotic susceptibilities


name: Letermovir | Isolate | Antibiotic susceptibilities


name: Choriogonadotropin.intact+Beta subunit | Serum, Plasma or Blood | Chemistry - non-challenge


name: Amyloid beta 42 peptide/Amyloid beta 40 peptide | Plasma | Chemistry - non-challenge


name: Glomerular filtration rate | Blood | Chemistry - non-challenge


name: Glomerular filtration rate | DBS | Chemistry - non-challenge


name: Glomerular filtration rate | Serum or Plasma | Chemistry - non-challenge


name: Glomerular filtration rate | Serum, Plasma or Blood | Chemistry - non-challenge


name: Glomerular filtration rate | Urine and Serum or Plasma | Chemistry - non-challenge


name: Anion gap | Blood arterial | Chemistry - non-challenge


name: Anion gap | Blood capillary | Chemistry - non-challenge


name: Anion gap | Blood cord arterial | Chemistry - non-challenge


name: Anion gap | Blood cord venous | Chemistry - non-challenge


name: Anion gap | Blood mixed venous | Chemistry - non-challenge


name: Anion gap | Blood venous | Chemistry - non-challenge


name: Anion gap | Serum, Plasma or Blood | Chemistry - non-challenge


name: Toxic substance | Urine | Drug toxicology


name: Drug class tested | XXX | Drug toxicology


name: Drugs | Serum or Plasma | Drug toxicology


name: Drugs | Tissue and Smears | Drug toxicology


name: Drugs | Unknown substance | Drug toxicology


name: Drugs | Vitreous fluid | Drug toxicology


name: Benzodiazepines panel | Serum, Plasma or Blood | Drug and Toxicology Panels


name: Opiates panel | Urine | Drug and Toxicology Panels


name: Total number of doses | Patient | Drug toxicology


name: Test dose included in cumulative AUC | Patient | Drug toxicology


name: Infusion stop date and time | Patient | Drug toxicology


name: Infusion start date and time | Patient | Drug toxicology


name: Busulfan target concentration | Patient | Drug toxicology


name: Busulfan area under the curve.cumulative | Plasma | Drug toxicology


name: Busulfan area under the curve | Plasma | Drug toxicology


name: Neutrophils.segmented/leukocytes | Blood | Hematology and Cell counts


name: Neutrophils.segmented/leukocytes | Bone marrow | Hematology and Cell counts


name: Neutrophils.segmented/leukocytes | Cerebral spinal fluid | Hematology and Cell counts


name: Neutrophils.segmented/leukocytes | Pericardial fluid | Hematology and Cell counts


name: Neutrophils.segmented/leukocytes | Peritoneal fluid | Hematology and Cell counts


name: Neutrophils.segmented/leukocytes | Pleural fluid | Hematology and Cell counts


name: Neutrophils.segmented/leukocytes | Synovial fluid | Hematology and Cell counts


name: Neutrophils.segmented/leukocytes | Stem cell product | Hematology and Cell counts


name: Neutrophils.band form/leukocytes | Pericardial fluid | Hematology and Cell counts


name: Neutrophils.band form/leukocytes | Peritoneal fluid | Hematology and Cell counts


name: Neutrophils.band form/leukocytes | Pleural fluid | Hematology and Cell counts


name: Neutrophils.band form/leukocytes | Synovial fluid | Hematology and Cell counts


name: Neutrophils.band form/leukocytes | Stem cell product | Hematology and Cell counts


name: Neutrophils/leukocytes | Blood cord | Hematology and Cell counts


name: Neutrophils/leukocytes | Body fluid | Hematology and Cell counts


name: Neutrophils/leukocytes | Dialysis fluid | Hematology and Cell counts


name: Neutrophils/leukocytes | Dialysis fluid peritoneal | Hematology and Cell counts


name: Neutrophils/leukocytes | Nose | Hematology and Cell counts


name: Neutrophils/leukocytes | Sputum | Hematology and Cell counts


name: Neutrophils/leukocytes | Vitreous fluid | Hematology and Cell counts


name: Basophils/leukocytes | Amniotic fluid | Hematology and Cell counts


name: Basophils/leukocytes | Blood cord | Hematology and Cell counts


name: Basophils/leukocytes | Dialysis fluid | Hematology and Cell counts


name: Basophils/leukocytes | Dialysis fluid peritoneal | Hematology and Cell counts


name: Basophils/leukocytes | Nose | Hematology and Cell counts


name: Basophils/leukocytes | Sputum | Hematology and Cell counts


name: Basophils/leukocytes | Vitreous fluid | Hematology and Cell counts


name: Basophils/leukocytes | XXX | Hematology and Cell counts


name: Basophils/leukocytes | Fetus | Hematology and Cell counts


name: Basophils/leukocytes | Fetus | Blood | Hematology and Cell counts


name: Basophils/leukocytes | Stem cell product | Hematology and Cell counts


name: Eosinophils/leukocytes | Blood cord | Hematology and Cell counts


name: Eosinophils/leukocytes | Dialysis fluid | Hematology and Cell counts


name: Eosinophils/leukocytes | Dialysis fluid peritoneal | Hematology and Cell counts


name: Eosinophils/leukocytes | Nose | Hematology and Cell counts


name: Eosinophils/leukocytes | Sputum | Hematology and Cell counts


name: Eosinophils/leukocytes | Stool | Hematology and Cell counts


name: Eosinophils/leukocytes | Vitreous fluid | Hematology and Cell counts


name: Eosinophils/leukocytes | XXX | Hematology and Cell counts


name: Eosinophils/leukocytes | Stem cell product | Hematology and Cell counts


name: Metamyelocytes/leukocytes | Stem cell product | Hematology and Cell counts


name: Myelocytes/leukocytes | Body fluid | Hematology and Cell counts


name: Myelocytes/leukocytes | Stem cell product | Hematology and Cell counts


name: Promyelocytes/leukocytes | Stem cell product | Hematology and Cell counts


name: Leukocytes other/leukocytes | Blood | Hematology and Cell counts


name: Leukocytes other/leukocytes | Body fluid | Hematology and Cell counts


name: Leukocytes other/leukocytes | Bronchial | Hematology and Cell counts


name: Leukocytes other/leukocytes | Cerebral spinal fluid | Hematology and Cell counts


name: Leukocytes other/leukocytes | Dialysis fluid peritoneal | Hematology and Cell counts


name: Leukocytes other/leukocytes | Vitreous fluid | Hematology and Cell counts


name: Smudge cells/leukocytes | Body fluid | Hematology and Cell counts


name: Lymphocytes.variant/leukocytes | Body fluid | Hematology and Cell counts


name: Lymphocytes.variant/leukocytes | Bronchial | Hematology and Cell counts


name: Lymphocytes.variant/leukocytes | Cerebral spinal fluid | Hematology and Cell counts


name: Lymphocytes.variant/leukocytes | Pericardial fluid | Hematology and Cell counts


name: Lymphocytes.variant/leukocytes | Peritoneal fluid | Hematology and Cell counts


name: Lymphocytes.variant/leukocytes | Pleural fluid | Hematology and Cell counts


name: Lymphocytes.variant/leukocytes | Synovial fluid | Hematology and Cell counts


name: Lymphocytes.variant/leukocytes | Stem cell product | Hematology and Cell counts


name: Lymphocytes/leukocytes | Blood cord | Hematology and Cell counts


name: Lymphocytes/leukocytes | Dialysis fluid | Hematology and Cell counts


name: Lymphocytes/leukocytes | Dialysis fluid peritoneal | Hematology and Cell counts


name: Lymphocytes/leukocytes | Sputum | Hematology and Cell counts


name: Lymphocytes/leukocytes | Tissue and Smears | Hematology and Cell counts


name: Lymphocytes/leukocytes | Vitreous fluid | Hematology and Cell counts


name: Lymphocytes/leukocytes | Fetus | Hematology and Cell counts


name: Lymphocytes/leukocytes | Fetus | Blood | Hematology and Cell counts


name: Lymphocytes/leukocytes | Stem cell product | Hematology and Cell counts


name: Macrophages/leukocytes | Bone marrow | Hematology and Cell counts


name: Macrophages/leukocytes | Dialysis fluid | Hematology and Cell counts


name: Macrophages/leukocytes | Vitreous fluid | Hematology and Cell counts


name: Monocytes/leukocytes | Blood cord | Hematology and Cell counts


name: Monocytes/leukocytes | Bronchial | Hematology and Cell counts


name: Monocytes/leukocytes | Dialysis fluid | Hematology and Cell counts


name: Monocytes/leukocytes | Dialysis fluid peritoneal | Hematology and Cell counts


name: Monocytes/leukocytes | Urine | Hematology and Cell counts


name: Monocytes/leukocytes | Vitreous fluid | Hematology and Cell counts


name: Monocytes/leukocytes | Stem cell product | Hematology and Cell counts


name: Monocytes+Macrophages/leukocytes | Blood | Hematology and Cell counts


name: Monocytes+Macrophages/leukocytes | Bone marrow | Hematology and Cell counts


name: Monocytes+Macrophages/leukocytes | Bronchial | Hematology and Cell counts


name: Monocytes+Macrophages/leukocytes | Cerebral spinal fluid | Hematology and Cell counts


name: Monocytes+Macrophages/leukocytes | Pericardial fluid | Hematology and Cell counts


name: Monocytes+Macrophages/leukocytes | Peritoneal fluid | Hematology and Cell counts


name: Monocytes+Macrophages/leukocytes | Pleural fluid | Hematology and Cell counts


name: Monocytes+Macrophages/leukocytes | Sputum | Hematology and Cell counts


name: Monocytes+Macrophages/leukocytes | Synovial fluid | Hematology and Cell counts


name: Monocytes+Macrophages/leukocytes | Tissue and Smears | Hematology and Cell counts


name: Monocytes+Macrophages/leukocytes | XXX | Hematology and Cell counts


name: Mononuclear cells/leukocytes | Blood | Hematology and Cell counts


name: Mononuclear cells/leukocytes | Body fluid | Hematology and Cell counts


name: Mononuclear cells/leukocytes | Bronchial | Hematology and Cell counts


name: Mononuclear cells/leukocytes | Cerebral spinal fluid | Hematology and Cell counts


name: Mononuclear cells/leukocytes | Dialysis fluid peritoneal | Hematology and Cell counts


name: Mononuclear cells/leukocytes | Gastric fluid | Hematology and Cell counts


name: Mononuclear cells/leukocytes | Pericardial fluid | Hematology and Cell counts


name: Mononuclear cells/leukocytes | Semen | Hematology and Cell counts


name: Mononuclear cells/leukocytes | Fetus | Hematology and Cell counts


name: Mononuclear cells/leukocytes | Fetus | Pleural fluid | Hematology and Cell counts


name: Mononuclear cells/leukocytes | Stem cell product | Hematology and Cell counts


name: Plasma cells/leukocytes | Blood cord | Hematology and Cell counts


name: Plasma cells/leukocytes | Bronchial | Hematology and Cell counts


name: Plasma cells/leukocytes | Pericardial fluid | Hematology and Cell counts


name: Plasma cells/leukocytes | Peritoneal fluid | Hematology and Cell counts


name: Plasma cells/leukocytes | Pleural fluid | Hematology and Cell counts


name: Plasma cells/leukocytes | Synovial fluid | Hematology and Cell counts


name: Blasts/leukocytes | Blood cord | Hematology and Cell counts


name: Blasts/leukocytes | Pericardial fluid | Hematology and Cell counts


name: Blasts/leukocytes | Peritoneal fluid | Hematology and Cell counts


name: Blasts/leukocytes | Pleural fluid | Hematology and Cell counts


name: Blasts/leukocytes | Synovial fluid | Hematology and Cell counts


name: Blasts/leukocytes | Fetus | Hematology and Cell counts


name: Blasts/leukocytes | Fetus | Blood | Hematology and Cell counts


name: Blasts/leukocytes | Stem cell product | Hematology and Cell counts


name: Unidentified cells/leukocytes | Blood | Hematology and Cell counts


name: Unidentified cells/leukocytes | Cerebral spinal fluid | Hematology and Cell counts


name: Unidentified cells/leukocytes | Pericardial fluid | Hematology and Cell counts


name: Unidentified cells/leukocytes | Peritoneal fluid | Hematology and Cell counts


name: Unidentified cells/leukocytes | Pleural fluid | Hematology and Cell counts


name: Unidentified cells/leukocytes | Synovial fluid | Hematology and Cell counts


name: Mesothelial cells/leukocytes | Blood | Hematology and Cell counts


name: Mesothelial cells/leukocytes | Cerebral spinal fluid | Hematology and Cell counts


name: Mesothelial cells/leukocytes | Dialysis fluid | Hematology and Cell counts


name: Mesothelial cells/leukocytes | Synovial fluid | Hematology and Cell counts


name: Mesothelial cells/leukocytes | Vitreous fluid | Hematology and Cell counts


name: Complement activity panel | Serum or Plasma | Hematology and Cell Count Panels


name: Lymphocytes/leukocytes | Blood | Cell markers


name: Lymphocytes/leukocytes | XXX | Cell markers


name: Chromosome analysis | Blood | Molecular pathology


name: CALR gene exon 9 targeted mutation analysis | Blood or Tissue | Mutations


name: IgH FR1 length in base pairs | XXX | Molecular pathology


name: IgH FR2 length in base pairs | XXX | Molecular pathology


name: IgH FR3 length in base pairs | XXX | Molecular pathology


name: Hereditary thyroid cancer multigene analysis | Blood or Tissue | Molecular pathology


name: Hereditary renal cancer multigene analysis | Blood or Tissue | Molecular pathology


name: Hereditary pancreatic cancer multigene analysis | Blood or Tissue | Molecular pathology


name: IgK gene Tube B length in base pairs | XXX | Molecular pathology


name: IgK gene Tube A length in base pairs | XXX | Molecular pathology


name: Breast Cancer recurrence risk multigene analysis | Tissue and Smears | Molecular pathology


name: TCRB gene Tube C length in base pairs | XXX | Rearrangements


name: TCRB gene Tube B length in base pairs | XXX | Rearrangements


name: TCRB gene Tube A length in base pairs | XXX | Rearrangements


name: TCRG gene Tube B length in base pairs | XXX | Rearrangements


name: TCRG gene Tube A length in base pairs | XXX | Rearrangements


name: Ulceration status | Tissue and Smears | Pathology


name: PD-L1 scoring method | Tissue and Smears | Pathology


name: Casts type not specified | Urine sediment | Urinalysis


name: Eosinophils/leukocytes | Urine | Urinalysis


name: Eosinophils/leukocytes | Urine sediment | Urinalysis


name: Stenosis degree | Tricuspid valve | Cardiac ultrasound


name: Circumference | Ankle | General body circumference


name: Specimen unacceptable for at least one condition


name: No BoNT-producing species of Clostridium isolated


name: Unsuitable for examination: insufficient quantity


name: No resistance throughout passive movement


name: Slight resistance, with no clear catch at a precise angle


name: Clear catch at a precise angle followed by release


name: Class II: Basal rales , S3, and elevated jugular venous pressure


name: Class IV: cardiogenic shock or hypotension (SBP < 90mmHg) and evidence of peripheral vasoconstriction


name: XR && RF|Upper extremity|Views|Laterality:ANY


name: Provision of patient generated medication list


name: Provision of medication list for public health and/or Centers for Disease Control and Prevention reporting


name: Provision of medication administration list


name: Specimen satisfactory for limited evaluation due to broken slide


name: Specimen exceeded allotted transport time


name: Specimen unsatisfactory for evaluation due to container leaking


name: Specimen satisfactory for limited evaluation due to container leaking


name: Patient name misspelled on specimen label


name: Collector identifier missing and/or illegible on specimen label


name: Patient identification missing and/or illegible on specimen label


name: Specimen identification label-to-laboratory requisition mismatch


name: Specimen received without matching laboratory requisition


name: Does not seek assistance when in an emergency


name: Active surveillance of prostate cancer not done


name: Escherichia coli not serogroup O26, O45, O103, O111, O121, O145, O157


name: Non-motile Escherichia coli serogroup not O26, O45, O103, O111, O121, O145, O157


name: Able to afford water service in residence


name: Household water insecurity due to limited financial resources


name: Household water insecurity due to water service disconnection notice


name: Household water insecurity due to water service disruption in geographical region


name: Household water insecurity due to water service disconnection


name: Household utility insecurity due to utility service disconnection


name: Household utility insecurity due to utility service disconnection notice


name: Household utility insecurity due to limited financial resources


name: Education about Tribally Designated Housing Entity


name: Referral to Tribally Designated Housing Entity


name: Implementation of the Confidentiality, Universal Education, Empowerment, and Support intervention


name: Able to afford energy service in residence


name: Reduced water service use in residence due to limited financial resources


name: Provision of discontinued medication list


name: Identifies as female-to-male transsexual gender


name: Identifies as male-to-female transsexual gender


name: Administration of coagulation factor replacement therapy


name: Administration of primary prophylactic coagulation replacement therapy


name: Administration of secondary prophylactic coagulation replacement therapy


name: Administration of tertiary prophylactic coagulation replacement therapy


name: Education about community solar subscription program


name: Education about household solar system installation assistance program


name: Evaluation of eligibility for household solar system installation assistance program


name: Assistance with application for household solar system installation assistance program


name: Assistance with application for community solar subscription program


name: Referral to household solar system installation assistance program


name: Referral to community solar subscription program


name: MRI of right sacroiliac joint without and with contrast


name: Suture control of bleeding duodenal ulcer


name: Metathesaurus CMS Formulary Reference File, 2020


name: ALUMINUM CHLOROHYDRATE 24.5 g in 100 g TOPICAL SPRAY [Dry Active Sport 3.5oz]


name: AVOBENZONE 5 mg in 1 g / OCTINOXATE 50 mg in 1 g / OCTOCRYLENE 30 mg in 1 g / OCTISALATE 22 mg in 1 g TOPICAL STICK [Snap-On Racing Sunscreen Lip Balm]


name: HOMOSALATE 80 mg in 1 g / OCTOCRYLENE 80 mg in 1 g / OCTISALATE 50 mg in 1 g / AVOBENZONE 30 mg in 1 g TOPICAL STICK [Snap-On Racing Sunscreen]


name: OCTOCRYLENE 3 g in 100 g / HOMOSALATE 5 g in 100 g / AVOBENZONE 2 g in 100 g / OCTISALATE 3 g in 100 g TOPICAL LIPSTICK [natural lip balm SPF15(unflavored) 01]


name: TITANIUM DIOXIDE 80 mg in 1 g / ZINC OXIDE 38 mg in 1 g TOPICAL CREAM [Proceuticals Private Label by TiZO Tinted Facial Mineral Sunscreen Backbar]


name: CAPRYLIC/CAPRIC TRIGLYCERIDE 3 mg in 15 mL / GLYCERIN 5 mg in 15 mL CUTANEOUS CREAM


name: ZINC OXIDE 20 g in 100 mL TOPICAL CREAM [Sunceutical SPF 50 Mineral Body Cream]


name: ZINC OXIDE 25 g in 25 g TOPICAL CREAM [Sea-Laminaria Kelp Day Cream SPF 30]


name: HOMOSALATE 14.4 mg in 180 mL / GLYCERIN 10.9 mg in 180 mL / OCTOCRYLENE 9 mg in 180 mL / AVOBENZONE 5.4 mg in 180 mL / OCTISALATE 7.2 mg in 180 mL TOPICAL LOTION [St Moriz suncare body sunscreen spf30]


name: HOMOSALATE 18 mg in 180 mL / AVOBENZONE 5.4 mg in 180 mL / OCTISALATE 7.2 mg in 180 mL / OCTOCRYLENE 18 mg in 180 mL TOPICAL LOTION [St Moriz suncare body sunscreen spf50]


name: ALUMINUM SESQUICHLOROHYDRATE 17.6 g in 100 g TOPICAL SPRAY [Dry Cool Sport 3.5oz]


name: OCTINOXATE 60 mg in 1 mL / ZINC OXIDE 29.4 mg in 1 mL TOPICAL EMULSION [LBEL CONCENTRE GLOBAL ANTI AGING SERUM FOUNDATION SPF 15 ALMENDRA 230N]


name: OCTOCRYLENE 5.4 mg in 180 mL / OCTISALATE 9 mg in 180 mL / TITANIUM DIOXIDE 5.4 mg in 180 mL TOPICAL LOTION [St Moriz suncare face sunscreen spf30]


name: OCTOCRYLENE 7 g in 100 g / AVOBENZONE 2 g in 100 g / OCTISALATE 5 g in 100 g TOPICAL GEL [BaliBody SPF15 Bronze Shimmering Tanning Gel]


name: OCTOCRYLENE 9 mg in 180 mL / HOMOSALATE 16.2 mg in 180 mL / AVOBENZONE 5.4 mg in 180 mL / OCTISALATE 7.2 mg in 180 mL TOPICAL LOTION [St Moriz suncare face sunscreen spf50]


name: TITANIUM DIOXIDE 7.75 g in 100 g / ZINC OXIDE 10 g in 100 g TOPICAL CREAM [EVEN DEFENSE Mineral Sunscreen Broad Spectrum SPF 30]


name: ZINC OXIDE 19.6 mg in 1 g / OCTINOXATE 50 mg in 1 g TOPICAL EMULSION [LBEL CONCENTRE GLOBAL ANTI AGING SERUM CONCEALER SPF 15 EYES FACE ALMENDRA 230]


name: Zinc Oxide 125 mg in 1 mL TOPICAL LOTION [SOS Face Guard Broad Spectrum Sunscreen SPF 30]


name: OCTINOXATE 7.5 g in 60 g TOPICAL EMULSION [Sunscreen Karina Skin Care SPF 15]


name: OCTISALATE 10 mg in 1 mL / HOMOSALATE 73 mg in 1 mL / OCTINOXATE 74.9 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL LOTION [DECORTE SUN SHELTER MULTI PROTECTION Sunscreen SPF 50 Broad Spectrum]


name: OCTOCRYLENE 8 g in 100 g / AVOBENZONE 3 g in 100 g / OCTISALATE 5 g in 100 g TOPICAL CREAM [Neptune Ave. High Dive Barrier Repair Moisturizer Broad Spectrum SPF 50]


name: ALLANTOIN, (R)- 0.5 g in 100 g TOPICAL SALVE [Scar Treatment Balm]


name: ZINC OXIDE 21.8 g in 100 g TOPICAL LIQUID [Sun Serum Drops]


name: {1 (1 ML mirikizumab-mrkz 100 MG/ML Auto-Injector) / 1 (2 ML mirikizumab-mrkz 100 MG/ML Auto-Injector) } Pack


name: {1 (1 ML mirikizumab-mrkz 100 MG/ML Auto-Injector [Omvoh]) / 1 (2 ML mirikizumab-mrkz 100 MG/ML Auto-Injector [Omvoh]) } Pack [Omvoh Prefilled Pen 300 MG Dose Carton]


name: {1 (1 ML mirikizumab-mrkz 100 MG/ML Prefilled Syringe) / 1 (2 ML mirikizumab-mrkz 100 MG/ML Prefilled Syringe) } Pack


name: {1 (1 ML mirikizumab-mrkz 100 MG/ML Prefilled Syringe [Omvoh]) / 1 (2 ML mirikizumab-mrkz 100 MG/ML Prefilled Syringe [Omvoh]) } Pack [Omvoh Prefilled Syringe 300 MG Dose Carton]


name: AVOBENZONE 30 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 70 mg in 1 mL TOPICAL CREAM [Jil Goorman Skincare Sun Guard SPF 30]


name: ZINC OXIDE 10 mg in 100 mg TOPICAL CREAM [Ceile SPF 30 prime PROTECT Broad Spectrum SPF 30 Sunscreen]


name: ZINC OXIDE 24 g in 100 mL TOPICAL CREAM [FRE BRONZE ME Sun-Kissed Mineral Sunscreen SPF 50]


name: ZINC OXIDE 150 mg in 1 mL TOPICAL LIQUID [FRE PLUMP ME PEPTIDE LIP TINT CASSIS SPF 30]


name: ALUMINUM ZIRCONIUM OCTACHLOROHYDRATE ANHYDROUS 16 g in 100 g TOPICAL GEL [Secret Cool Waterlily Clear]


name: ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY 16 g in 100 g TOPICAL GEL [Secret Mountain Air Clear]


name: AVOBENZONE 0.918 g in 30 mL / OCTINOXATE 2.038 g in 30 mL / OCTISALATE 1.377 g in 30 mL / OCTOCRYLENE 0.612 g in 30 mL TOPICAL CREAM [CHARLOTTE TILBURY Broad Spectrum SPF 50 Sunscreen Invisible UV Flawless Poreless Primer]


name: AVOBENZONE 20 mg in 1 mL / HOMOSALATE 70 mg in 1 mL / OCTISALATE 40 mg in 1 mL / OCTOCRYLENE 17 mg in 1 mL TOPICAL CREAM [RODAN - FIELDS ESSENTIALS Body Sunscreen BROAD SPECTRUM SPF 30]


name: AVOBENZONE 3 g in 100 g / HOMOSALATE 8 g in 100 g / OCTOCRYLENE 10 g in 100 g / OCTISALATE 5 g in 100 g TOPICAL STICK [Hydraboost Lip Treatment]


name: AVOBENZONE 3 g in 100 g / OCTOCRYLENE 10 g in 100 g / OCTISALATE 5 g in 100 g / HOMOSALATE 15 g in 100 g TOPICAL STICK [Meijer SPF 50 Sunscreen]


name: HOMOSALATE 4 g in 100 g / OCTISALATE 4 g in 100 g / OCTOCRYLENE 3 g in 100 g / AVOBENZONE 2 g in 100 g TOPICAL LOTION [BANANA BOAT]


name: HOMOSALATE 75 mg in 1 mL / OCTISALATE 50 mg in 1 mL / AVOBENZONE 30 mg in 1 mL / OCTOCRYLENE 26 mg in 1 mL / OXYBENZONE 20 mg in 1 mL TOPICAL CREAM [StriVectin-SH NIA-114 UVA UVB Shields SPF 30]


name: OCTOCRYLENE 5 g in 100 g / HOMOSALATE 7.5 g in 100 g / AVOBENZONE 2.7 g in 100 g / OCTISALATE 4.5 g in 100 g TOPICAL LOTION [BANANA BOAT]


name: OCTOCRYLENE 5.7 g in 100 g / OCTISALATE 4.5 g in 100 g / AVOBENZONE 1.9 g in 100 g TOPICAL AEROSOL, SPRAY [BANANA BOAT]


name: OCTOCRYLENE 70 mg in 1 mL / HOMOSALATE 50 mg in 1 mL / OCTISALATE 50 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL CREAM [Garnier SkinActive Vitamin(E) C UV Brightening Daily Broad Spectrum SPF 30]


name: ZINC OXIDE 10.9 g in 100 g TOPICAL LOTION [Safe Sea SPF 30]


name: {21 (ethinyl estradiol 0.035 MG / norethindrone 0.4 MG Chewable Tablet) / 7 (ferrous fumarate 75 MG Chewable Tablet) } Pack [Xelria Fe 28 Day]


name: {21 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Oral Tablet) / 7 (ferrous fumarate 75 MG Oral Tablet) } Pack [Feirza 1/20 28 Day]


name: {21 (ethinyl estradiol 0.03 MG / norethindrone acetate 1.5 MG Oral Tablet) / 7 (ferrous fumarate 75 MG Oral Tablet) } Pack [Feirza 1.5/30 28 Day]


name: bupivacaine/lidocaine/triamcinolone 0.25%-1%-40 mg/mL injectable kit


name: BD Safetyglide 1 mL 27G x 3/8" TB Syringe


name: Heali Kin Tape Infused Magnesium And Menthol


name: Heali Kinesiology Tape For Plantar Fasciitis


name: Heali Kinesiology Tape Pain Relief Beige


name: Heali Kinesiology Tape Pain Relief Black


name: Heali Pro Kinesiology Tape Blue Splatter


name: Omnipod 5 DexG7G6 Pods (Gen 5) Govt Use Only


name: Seni Active Classic Plus Underwear Large


name: Seni Active Classic Plus Underwear Medium


name: Seni Active Classic Plus Underwear X-Large


name: Seni Active Super Plus Underwear X-Large


name: Seni Active Super Plus Underwear XX-Large


name: Seni Man Active Light Bladder Control Guard


name: Seni Soft Classic Dry Underpads Large Surface


name: Seni Soft Super Dry Underpads Large Surface


name: Other antineoplastic agents (cont.) in ATC


name: emtricitabine, tenofovir alafenamide and dolutegravir


name: pyrazinamide, ethambutol, isoniazid and lomefloxacin


name: pyrazinamide, ethambutol, protionamide and lomefloxacin


name: rifabutin, pyrazinamide and protionamide


name: rifampicin, pyrazinamide, isoniazid and levofloxacin


name: Isocitrate dehydrogenase (IDH) inhibitors, antineoplastic


name: {5 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Oral Tablet) / 7 (ethinyl estradiol 0.03 MG / norethindrone acetate 1 MG Oral Tablet) / 9 (ethinyl estradiol 0.035 MG / norethindrone acetate 1 MG Oral Tablet) / 7 (ferrous fumarate 75 MG Oral Tablet) } Pack [Xarah Fe 28 Day]


name: vitamin B6 (as pyridoxine hydrochloride and pyridoxal-5-phosphate)


name: ZINC OXIDE 140 mg in 1 g / TITANIUM DIOXIDE 37 mg in 1 g TOPICAL LOTION [Evereden Fluid Silk Mineral Sunscreen PRO SPF50]


name: ZINC OXIDE 188 mg in 1 g TOPICAL SPONGE [Tri-water sheer mineral sunscreen cushion SPF30]


name: ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY 19 g in 100 g TOPICAL CREAM [Old Spice Sweat Defense Deep Sea]


name: AVOBENZONE 3 mg in 100 mg / HOMOSALATE 10 mg in 100 mg / OCTISALATE 5 mg in 100 mg / OCTOCRYLENE 10 mg in 100 mg TOPICAL OINTMENT [Everyday Humans Sunscreen Lip Balm Broad Spectrum SPF30]


name: ZINC OXIDE 22.1 g in 100 g TOPICAL POWDER [Brush On Block SPF 30 Mineral Powder Translucent Zinc Only-Refill]


name: STIMULATOR,NEUROMUSCULAR GEKO DEVICE T-3


name: STIMULATOR,NEUROMUSCULAR GEKO DEVICE W-3


name: TRACH TUBE,SZ 6 BIVONA SMITHS #60AFHXL60


name: CATHERIZATION SET,W/O CATH APOGEE PLUS #6100A


name: DRESSING,ZETUVIT PLUS SILICONE BORDER 5IN X 6IN #413908


name: CATHETER,INTERMITTENT COUDE 12FR COLOPLAST #20102


name: OCTINOXATE 1.05 g in 15 g / OCTISALATE 0.67 g in 15 g / OCTOCRYLENE 0.3 g in 15 g TOPICAL STICK [OrgaPlus Ultra Pure Sun EX 15g]


name: AVOBENZONE 30 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 70 mg in 1 mL TOPICAL CREAM [Atlanta Acne Specialist Everyday Sunscreen SPF 30]


name: AVOBENZONE 30 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 70 mg in 1 mL TOPICAL CREAM [Seven Thirty Daily Habit Broad Spectrum SPF 30]


name: ZINC OXIDE 12 g in 100 mL TOPICAL LOTION [Brush On Block Sheer Genius SPF 50 Mineral Moisture]


name: ZINC OXIDE 150 mg in 1 g TOPICAL CREAM [TiZO Tinted Moisturizing Serum - Deep]


name: Ultra-Fine U-100 12.7mm 30G 0.3mL Insulin Syringe


name: Ultra-Fine U-100 12.7mm 30G 0.5mL Insulin Syringe


name: Ultra-Fine U-100 12.7mm 30G 1mL Insulin Syringe


name: Ultra-Fine U-100 6mm 31G 0.3mL Insulin Syringe


name: Ultra-Fine U-100 6mm 31G 0.5mL Insulin Syringe


name: Ultra-Fine U-100 6mm 31G 1mL Insulin Syringe


name: Ultra-Fine U-100 8mm 31G 0.3mL Insulin Syringe


name: Ultra-Fine U-100 8mm 31G 0.5mL Insulin Syringe


name: Ultra-Fine U-100 8mm 31G 1mL Insulin Syringe


name: embecta U-100 12.7mm 28G 1mL Insulin Syringe


name: embecta U-100 16mm 27G 1mL Insulin Syringe


name: Pedialyte Electrolyte Powder for Solution (Grape)


name: SUN BURNT Advanced Sun Recovery Daily Moisturizing Lotion


name: nutritional therapy for PKU with iron no.12 8.4 gram-90 kcal/100 mL ORAL LIQUID (ML)


name: nutritional therapy for phenylketonuria (PKU) no.66 80 gram-333 kcal/100 gram ORAL POWDER (GRAM)


name: nutritional therapy for phenylketonuria (PKU) no.66 80 gram-333 kcal/100 gram ORAL POWDER IN PACKET (EA)


name: nutritional therapy for phenylketonuria (PKU) no.74 60 gram-306 kcal/100 gram ORAL POWDER IN PACKET (EA)


name: nutritional therapy for phenylketonuria(PKU) no.56 73.6 gram-396 kcal/100 gram ORAL GRANULES, DELAYED RELEASE


name: nutritional therapy, metabolic disorder, methionine-free 15 gram-97 kcal/130 mL ORAL LIQUID IN PACKET (ML)


name: syringe with cannula, disposable, 1 mL and atomizer NASAL COMBINATION PACKAGE (EA)


name: almond oil/silicon dioxide,colloidal/BHT/sweetleaf ORAL SUSPENSION, ORAL (FINAL DOSE FORM)


name: ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY 16 g in 100 g TOPICAL GEL [Secret Light Ocean Breeze Clear]


name: ZINC OXIDE 3.4 g in 100 mL / TITANIUM DIOXIDE 4.5 g in 100 mL TOPICAL OIL [Brush On Block Sun Shine SPF 30 Protective Lip Oil Peony Tint]


name: {24 (ethinyl estradiol 0.025 MG / norethindrone 0.8 MG Chewable Tablet) / 4 (ferrous fumarate 75 MG Chewable Tablet) } Pack [Galbriela 28 Day]


name: {28 (norethindrone 0.35 MG Oral Tablet) } Pack [Orquidea 28 Day]


name: {21 (ethinyl estradiol 0.035 MG / ethynodiol diacetate 1 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Valtya 1/35 28 Day]


name: {21 (ethinyl estradiol 0.05 MG / ethynodiol diacetate 1 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Valtya 1/50 28 Day]


name: Cream, Multi Ingredient Topical application Cream [Palmer's Vitamin E Concentrated]


name: Cream, Multi Ingredient Topical application Cream [Palmer's Vitamin E Body Butter]


name: Avobenzone/Homosalate/Octisalate/Octocrylene 3%-15%-5%-10% Topical application Lotion [Quality Choice Baby Sunscreen]


name: Avobenzone/Homosalate/Octisalate/Octocrylene 3%-15%-5%-6% Topical application Lotion [Quality Choice Ultimate Sunscreen]


name: Betamethasone Acetate/Betamethasone Sodium Phosphate;Iodixanol;Isopropyl Alcohol;Lidocaine Hydrochloride;Povidone Iodine 6 MG/1 ML; 320 MG/1 ML; 70%; 1%; 10% Multiple Routes Kit


name: betamethasone / florfenicol / terbinafine


name: TITANIUM DIOXIDE 100 mg in 1 mL / ZINC OXIDE 80 mg in 1 mL TOPICAL CREAM [Aruba Aloe Broad Spectrum SPF 30 Mineral Sunscreen]


name: OCTISALATE 5 g in 100 g / AVOBENZONE 3 g in 100 g / HOMOSALATE 7 g in 100 g TOPICAL CREAM [Tula 24-7 Moisture Plus SPF 30 Hydrating Day with Sunscreen Broad Spectrum SPF 30]


name: AVOBENZONE 30 mg in 0.001 L / OCTISALATE 50 mg in 0.001 L / OCTOCRYLENE 70 mg in 0.001 L TOPICAL CREAM [Pacific Mango Sunscreen SPF 30]


name: ETHYLHEXYL METHOXYCINNAMATE 8.49405 g in 100 mL / TITANIUM DIOXIDE 3.9 g in 100 mL / ALUMINUM HYDROXIDE 0.6 g in 100 mL / ETHYLHEXYL SALICYLATE 4 g in 100 mL / PHENYLBENZIMIDAZOLE SULFONIC ACID 1 g in 100 mL / ZINC OXIDE 10.45 g in 100 mL TRANSDERMAL CREAM


name: LIDOCAINE HYDROCHLORIDE 3.5 mg in 100 mL TOPICAL LIQUID [Sunset Novelties Herquake]


name: ZINC OXIDE 13.1 g in 100 mL TOPICAL LIQUID [Skin Solution Multi-Serum Skin Tint SPF 40]


name: TITANIUM DIOXIDE 4 g in 100 mL / PHENYLBENZIMIDAZOLE SULFONIC ACID 3.2 g in 100 mL / HOMOSALATE 1 g in 100 mL / ZINC OXIDE 0.6 g in 100 mL / ETHYLHEXYL SALICYLATE 5 g in 100 mL CUTANEOUS CREAM


name: {28 (norethindrone 0.35 MG Oral Tablet) } Pack [Meleya 28 Day]


name: TITANIUM DIOXIDE 2.76 g in 100 mL / ETHYLHEXYL SALICYLATE 5 g in 100 mL / PHENYLBENZIMIDAZOLE SULFONIC ACID 3.2 g in 100 mL / ZINC OXIDE 2.85 g in 100 mL CUTANEOUS CREAM


name: OCTINOXATE 75 mg in 1 g / MERADIMATE 50 mg in 1 g / OXYBENZONE 30 mg in 1 g / OCTISALATE 50 mg in 1 g CUTANEOUS LOTION [Pro-Tect Sports Sunscreen SPF 20]


name: OCTINOXATE 75 mg in 1 mL / TITANIUM DIOXIDE 50 mg in 1 mL TOPICAL LIQUID [Laura Mercier Flawless Skin Daily Face Shield SPF 40]


name: OCTOCRYLENE 56 mg in 1 g / AVOBENZONE 30 mg in 1 g / HOMOSALATE 105 mg in 1 g / OCTISALATE 35 mg in 1 g TOPICAL AEROSOL, SPRAY [Bondi Sands Fragrance Free Face SPF 50 Sunscreen Mist]


name: ZINC OXIDE 25 g in 100 g TOPICAL CREAM [Sky and Sol Body Sunscreen]


name: ZINC OXIDE 25 g in 100 g TOPICAL CREAM [Sky and Sol Sunscreen SPF 50]


name: ASCORBIC ACID 20 mg in 100 mL TOPICAL LIQUID [Srripo 20% VITAMIN C SERUM]


name: FENBENDAZOLE 250 g in 250 g NOT APPLICABLE POWDER


name: FENBENDAZOLE 500 g in 500 g NOT APPLICABLE POWDER


name: ZINC OXIDE 25 g in 100 g TOPICAL OINTMENT [Sky and Sol Intense Healing Lip Jelly]


name: {6 (nirmatrelvir 150 MG Oral Tablet) / 5 (ritonavir 100 MG Oral Tablet) } Pack


name: {6 (nirmatrelvir 150 MG Oral Tablet) / 5 (ritonavir 100 MG Oral Tablet) } Pack [Paxlovid 300 MG /100 MG ; 150 MG / 100 MG Dose Pack]


name: ZINC OXIDE 142.8 mg in 1 mL TOPICAL LOTION [Well People Daygleamer Liquid Mineral Sunscreen SPF 34]


name: ZINC OXIDE 24.05 g in 100 g TOPICAL CREAM [Hi papa KIDS MINERAL FACE SUNSCREEN]


name: ZINC OXIDE 25 g in 100 g CUTANEOUS CREAM


name: PHENOXYBENZAMINE HYDROCHLORIDE 1 g in 1 g NOT APPLICABLE POWDER


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 90 mg in 1 mL / OCTISALATE 45 mg in 1 mL / OCTOCRYLENE 50 mg in 1 mL TOPICAL CREAM [Purito Sunday Adventure Sunscreen SPF 50, 50 mL]


name: HOMOSALATE 6 g in 50 mL / OCTOCRYLENE 5 g in 50 mL / OCTISALATE 4.5 g in 50 mL / ZINC OXIDE 10.38 g in 50 mL TOPICAL CREAM [Cell Fusion C Laser UV Defense Sunscreen Broad Spectrum SPF 50]


name: HOMOSALATE 7.3 g in 50 mL / OCTOCRYLENE 9 g in 50 mL / OCTISALATE 5 g in 50 mL / AVOBENZONE 3 g in 50 mL TOPICAL CREAM [Cell Fusion C Aquatica UV Defense Sunscreen Broad Spectrum SPF 50]


name: HOMOSALATE 9.5 g in 100 g / OCTOCRYLENE 5 g in 100 g / OCTISALATE 4.5 g in 100 g / AVOBENZONE 3 g in 100 g TOPICAL STICK [Cell Fusion C Airy Stick Sunscreen Broad Spectrum SPF 50]


name: AVOBENZONE 2.7 g in 100 g / HOMOSALATE 9 g in 100 g / OCTISALATE 4.5 g in 100 g / OCTOCRYLENE 6 g in 100 g TOPICAL SPRAY [Smart Care SPORT ultra CLEAR SUNSCREEN SPF 50]


name: AVOBENZONE 3 g in 100 g / HOMOSALATE 10 g in 100 g / OCTISALATE 5 g in 100 g / OCTOCRYLENE 6 g in 100 g TOPICAL SPRAY [Smart Care Barbie KIDS SUNSCREEN SPF 50]


name: AVOBENZONE 3 g in 100 g / OCTINOXATE 7.5 g in 100 g / OCTISALATE 5 g in 100 g / OXYBENZONE 4 g in 100 g TOPICAL CREAM [YOUR TINTED MOISTURIZER HYDRATING ANTI AGING BROAD SPECTRUM SPF 30]


name: TITANIUM DIOXIDE 4.5 g in 100 g / ZINC OXIDE 6.5 g in 100 g TOPICAL LOTION [Smart Care SPORT ultra SUNSCREEN SPF 50]


name: ZINC OXIDE 16.1 g in 100 g TOPICAL CREAM [Truskin SPF 30 Mineral Sunscreen Facial Serum]


name: ZINC OXIDE 188 mg in 1 g TOPICAL LOTION [Ultra sheer mineral sunscreen PRO SPF30]


name: ZINC OXIDE 21.7 g in 100 mL TOPICAL LOTION [DreamBeam Sunscreen Sunlit]


name: ZINC OXIDE 25 g in 100 g TOPICAL CREAM [Sky and Sol Face Sunscreen SPF 50]


name: ZINC OXIDE 7.5 g in 100 mL TOPICAL LOTION [Revealer Skin-Improving Foundation]


name: ZINC OXIDE 9.4 mg in 100 mL TOPICAL LOTION [Daily Sunscreen Broad Spectrum SPF 30 UVA UVB]


name: ZINC OXIDE 67 mg in 1 mL TOPICAL EMULSION [Dolce and Gabbana Blueberry Nutri Tint SPF 20 10N Light Medium]


name: ALUMINUM CHLOROHYDRATE 100 mg in 1 g TOPICAL AEROSOL, SPRAY [Brut Classic Antiperspirant and Deodorant]


name: OCTINOXATE 7.5 g in 1 mL / OXYBENZONE 6 g in 1 mL / OCTISALATE 5 g in 1 mL TOPICAL LOTION [Avon Skin-So-Soft Bug Guard plus SPF 30 Sunscreen Gentle Breeze Insect Repellent Sunscreen]


name: ZINC OXIDE 19 g in 50 mL TOPICAL CREAM [Cell Fusion C Derma UV Mineral Sunscreen Broad Spectrum SPF 50]


name: CURCUMA LONGA (TURMERIC) ROOT POWDER 5 g in 100 mL EXTRACORPOREAL AEROSOL, FOAM [FluMisch Turmeric Kojic Acid Facial Cleanser]


name: KOJIC ACID 1 g in 100 mL / ASCORBIC ACID 2 g in 100 mL / GLUTATHIONE 1 g in 100 mL / NIACINAMIDE 1 g in 100 mL EXTRACORPOREAL LIQUID [FEELSHION Dark Spot Remover Serum]


name: TOCOPHEROL 1 g in 100 mL / BUTYROSPERMUM PARKII (SHEA) BUTTER 3 g in 100 mL / PRUNUS ARMENIACA (APRICOT) KERNEL EXTRACT 2 g in 100 mL / NIACINAMIDE 0.05 g in 100 mL / BUTYLENE GLYCOL 5 g in 100 mL / ASCORBIC ACID 0.05 g in 100 mL EXTRACORPOREAL CREAM [QIDILA Whitening Skin Lightening Cream]


name: ZINC OXIDE 170 mg in 1 mL TOPICAL CREAM [Dr Loretta Universal Glow Daily Defense SPF 40]


name: ZINC OXIDE 220 mg in 1 g TOPICAL LIQUID [Sheer Tint Mineral SPF Serum - Medium Medium]


name: meningococcal group B vaccine / Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine / Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine / Neisseria meningitidis serogroup Y oligosaccharide diphtheria CRM197 protein conjugate vaccine


name: AVOBENZONE 3 g in 100 g / HOMOSALATE 10 g in 100 g / OCTISALATE 5 g in 100 g / OCTOCRYLENE 6 g in 100 g TOPICAL SPRAY [Smart Care SPIDER-MAN KIDS SUNSCREEN SPF 50]


name: Living Arrangements:-:RptPeriod:^Patient:-:CMS Assessment (105176-2)


name: I have indicated all the devices needed:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Functional assessment standardized items (FASI) - v1.2:-:RptPeriod:^Patient:-:CMS Assessment


name: Functional assessment standardized items (FASI) - v1.2


name: Outcome and assessment information set (OASIS) form - version E1 - Start of Care:-:RptPeriod:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version E1 - Start of Care


name: Outcome and assessment information set (OASIS) form - version E1:-:RptPeriod:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version E1


name: Outcome and assessment information set (OASIS) form - version E1 - Resumption of Care:-:RptPeriod:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version E1 - Resumption of Care


name: Outcome and assessment information set (OASIS) form - version E1 - Death at Home:-:RptPeriod:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version E1 - Death at Home


name: Outcome and assessment information set (OASIS) form - version E1 - Transfer to an Inpatient Facility:-:RptPeriod:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version E1 - Transfer to an Inpatient Facility


name: Outcome and assessment information set (OASIS) form - version E1 - Follow Up:-:RptPeriod:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version E1 - Follow Up


name: Outcome and assessment information set (OASIS) form - version E1 - Discharge from Agency:-:RptPeriod:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version E1 - Discharge from Agency


name: Hospice Outcomes and Patient Evaluation (HOPE) Admission v1.0:-:RptPeriod:^Patient:-:CMS Assessment


name: Hospice Outcomes and Patient Evaluation (HOPE) Admission v1.0


name: Hospice Outcomes and Patient Evaluation (HOPE) v1.0:-:RptPeriod:^Patient:-:CMS Assessment


name: Hospice Outcomes and Patient Evaluation (HOPE) v1.0


name: Hospice Outcomes and Patient Evaluation (HOPE) Discharge v1.0:-:RptPeriod:^Patient:-:CMS Assessment


name: Hospice Outcomes and Patient Evaluation (HOPE) Discharge v1.0


name: Site of Service at Admission:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Patient ZIP Code:Loc:RptPeriod:^Patient:Nom:CMS Assessment


name: Date the patient or responsible party was first asked about preference regarding the use of CPR:Date:RptPeriod:^Patient:Qn:CMS Assessment


name: Date the patient or responsible party was first asked about preference regarding the use of CPR


name: Was the patient or responsible party asked about preference regarding the use of cardiopulmonary resuscitation:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Was the patient or responsible party asked about preference regarding the use of cardiopulmonary resuscitation


name: Other Life-Sustaining Treatment Preferences:-:RptPeriod:^Patient:-:CMS Assessment


name: Other Life-Sustaining Treatment Preferences


name: Was the patient or responsible party asked about preferences regarding life-sustaining treatments other than CPR:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Was the patient or responsible party asked about preferences regarding life-sustaining treatments other than CPR


name: Date the patient or responsible party was first asked about preferences regarding life-sustaining treatments other than CPR:Date:RptPeriod:^Patient:Qn:CMS Assessment


name: Date the patient or responsible party was first asked about preferences regarding life-sustaining treatments other than CPR


name: Date the patient and or caregiver was first asked about spiritual or existential concerns:Date:RptPeriod:^Patient:Qn:CMS Assessment


name: Date the patient and or caregiver was first asked about spiritual or existential concerns


name: Was the patient and or caregiver asked about spiritual or existential concerns:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Was the patient and or caregiver asked about spiritual or existential concerns


name: Spiritual or Existential Concerns:-:RptPeriod:^Patient:-:CMS Assessment


name: Date the patient or responsible party was first asked about preference regarding hospitalization:Date:RptPeriod:^Patient:Qn:CMS Assessment


name: Date the patient or responsible party was first asked about preference regarding hospitalization


name: Was the patient or responsible party asked about preference regarding hospitalization:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Was the patient or responsible party asked about preference regarding hospitalization


name: Comorbidities and Co-existing Conditions:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Comorbidities and Co-existing Conditions


name: Death is Imminent:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Was the patient screened for pain:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Date of first screening for pain:Date:RptPeriod:^Patient:Qn:CMS Assessment


name: Patient's pain severity:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Was a comprehensive pain assessment done:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Was a comprehensive pain assessment done


name: Type of standardized pain tool used:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Pain Active Problem:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Comprehensive Pain Assessment:-:RptPeriod:^Patient:-:CMS Assessment


name: Date of comprehensive pain assessment:Date:RptPeriod:^Patient:Qn:CMS Assessment


name: Comprehensive pain assessment included:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Screening for Shortness of Breath:-:RptPeriod:^Patient:-:CMS Assessment


name: Was the patient screened for shortness of breath:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Was the patient screened for shortness of breath


name: Date of first screening for shortness of breath:Date:RptPeriod:^Patient:Qn:CMS Assessment


name: Date of first screening for shortness of breath


name: Did the screening indicate the patient had shortness of breath:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Did the screening indicate the patient had shortness of breath


name: Treatment for Shortness of Breath:-:RptPeriod:^Patient:-:CMS Assessment


name: Was treatment for shortness of breath initiated:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Was treatment for shortness of breath initiated


name: Date treatment for shortness of breath initiated:Date:RptPeriod:^Patient:Qn:CMS Assessment


name: Date treatment for shortness of breath initiated


name: Date of symptom impact screening:Date:RptPeriod:^Patient:Qn:CMS Assessment


name: Was a symptom impact screening completed:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Was a symptom impact screening completed


name: Symptom Impact Screening:-:RptPeriod:^Patient:-:CMS Assessment


name: Symptom Impact - Pain:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Symptom Impact - Shortness of breath:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Symptom Impact - Anxiety:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Symptom Impact - Vomiting:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Symptom Impact - Nausea:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Symptom Impact - Diarrhea:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Symptom Impact - Constipation:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Symptom Impact - Agitation:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: SFV Symptom Impact - Agitation:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: SFV Symptom Impact - Constipation:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: SFV Symptom Impact - Diarrhea:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: SFV Symptom Impact - Vomiting:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: SFV Symptom Impact - Nausea:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: SFV Symptom Impact - Anxiety:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: SFV Symptom Impact - Shortness of breath:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: SFV Symptom Impact - Shortness of breath


name: SFV Symptom Impact - Pain:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Symptom Follow-up Visit:-:RptPeriod:^Patient:-:CMS Assessment


name: Was an in-person SFV completed:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Date of in-person SFV:Date:RptPeriod:^Patient:Qn:CMS Assessment


name: Reason SFV Not Completed:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: SFV Symptom Impact:-:RptPeriod:^Patient:-:CMS Assessment


name: Skin Conditions. Does the patient have one or more skin conditions:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Skin Conditions. Does the patient have one or more skin conditions


name: Types of Skin Conditions:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Skin and Ulcer or Injury Treatments:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Date bowel regimen initiated or continued:Date:RptPeriod:^Patient:Qn:CMS Assessment


name: Date bowel regimen initiated or continued


name: Was a bowel regimen initiated or continued:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Was a bowel regimen initiated or continued


name: Date PRN opioid initiated or continued:Date:RptPeriod:^Patient:Qn:CMS Assessment


name: Was a PRN opioid initiated or continued:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Was a scheduled opioid initiated or continued:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Was a scheduled opioid initiated or continued


name: Date scheduled opioid initiated or continued:Date:RptPeriod:^Patient:Qn:CMS Assessment


name: Date scheduled opioid initiated or continued


name: Reason for Discharge:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Hospice Outcomes and Patient Evaluation (HOPE) Update Visit v1.0:-:RptPeriod:^Patient:-:CMS Assessment


name: Hospice Outcomes and Patient Evaluation (HOPE) Update Visit v1.0


name: Administrative information:-:RptPeriod:^Patient:-:CMS Assessment (106935-0)


name: Hospice Home Care (Routine Home Care (RHC)) Provided in a Hospice Facility


name: Inpatient Hospice Facility (General Inpatient (GIP))


name: Nursing Long Term Care (LTC) or Non-Skilled Nursing Facility (NF)


name: Yes, but the patient/responsible party refused to discuss


name: Cardiovascular (excluding heart failure)


name: Not at all - symptom does not affect the patient, including symptoms well-controlled with current treatment


name: Not applicable (the patient is not experiencing the symptom)


name: Patient and/or caregiver declined an in-person visit.


name: Patient unavailable (e.g., in ED, hospital, travel outside of service area, expired).


name: Attempts to contact patient and/or caregiver were unsuccessful.


name: Open lesion(s) other than ulcers, rash, or skin tear (cancer lesions)


name: No, but there is documentation of why a bowel regimen was not initiated or continued


name: With others in the home (e.g., family, friends, or paid caregiver)


name: Congregate home (e.g., assisted living or residential care home)


name: Inpatient facility (e.g., skilled nursing facility, nursing home, inpatient hospice, hospital)


name: Does not have a permanent home (e.g., has unstable housing or is experiencing homelessness)


name: Around-the-clock (24 hours a day with few exceptions)


name: Regular daytime (all day every day with few exceptions)


name: Regular nighttime (all night every night with few exceptions)


name: angioplasty of superior mesenteric artery (treatment)


name: angioplasty of common femoral artery (treatment)


name: angioplasty of celiac artery (treatment)


name: angioplasty of popliteal artery (treatment)


name: percutaneous transluminal angioplasty of renal artery (treatment)


name: percutaneous transluminal balloon angioplasty of renal artery


name: Mirodry wound matrix, per square centimeter (add-on, list separately in addition to primary procedure)


name: Myriad matrix, per square centimeter (add-on, list separately in addition to primary procedure)


name: Foundation drs solo, per square centimeter (add-on, list separately in addition to primary procedure)


name: Corplex p or theracor p or allacor p, per milligram


name: Manual transanal irrigation system, includes water reservoir, pump, tubing, and accessories, without catheter, any type


name: Gradient compression wrap with adjustable straps, full leg, each, custom


name: Gradient compression wrap with adjustable straps, foot, each, custom


name: Gradient compression wrap with adjustable straps, below knee, each, custom


name: Gradient compression wrap with adjustable straps, arm, each, custom


name: Gradient compression garment, not otherwise specified, for nighttime use, each


name: Gradient compression garment, not otherwise specified, for daytime use, each


name: Gradient compression wrap with adjustable straps, above knee, each, custom


name: Simulation angiogram with use of a pressure-generating catheter (e.g., one-way valve, intermittently occluding), inclusive of all radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance necessary to complete the angiogram, for subsequent therapeutic radioembolization of tumors


name: Bronchoscopy, rigid or flexible, non-thermal transbronchial ablation of lesion(s) by pulsed electric field (pef) energy, including fluoroscopic and/or ultrasound guidance, when performed, with computed tomography acquisition(s) and 3d rendering, computer-assisted, image-guided navigation, and endobronchial ultrasound (ebus) guided transtracheal and/or transbronchial sampling (e.g., aspiration[s]/biopsy[ies]) of lung(s) and all mediastinal and/or hilar lymph node stations or structures, and therapeutic intervention(s)


name: 3d predictive model generation for pre-planning of a cardiac procedure, using data from cardiac computed tomographic angiography and/or magnetic resonance imaging with report


name: Wheelchair transportation securement system, any type includes all components and accessories


name: Wheelchair transit securement system, includes all components and accessories


name: Wheelchair accessory, manual swingaway, retractable or removable mounting hardware used with joystick or other drive control interface


name: Wheelchair accessory, manual swingaway, retractable or removable mounting hardware for headrest, cushioned, any type


name: Wheelchair accessory, manual swingaway, retractable or removable mounting hardware for lateral trunk or hip support, any type


name: Static progressive stretch finger device, extension and/or flexion, with or without range of motion adjustment, includes all components and accessories


name: Quantitative software measurements of cardiac volume, cardiac chambers volumes and left ventricular wall mass derived from ct scan(s) data of the chest/heart (with or without contrast)


name: 3d radiodensity-value bone imaging, algorithm derived, from previous magnetic resonance examination of the same anatomy


name: Infectious agent detection by nucleic acid (dna or rna); hepatitis c, screening, amplified probe technique


name: Cervical-thoracic-lumbar-sacral-orthoses (ctlso), anterior-posterior-lateral control, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise


name: Ankle foot orthosis, rigid anterior tibial section, total carbon fiber or equal material, prefabricated, off-the-shelf


name: Ankle foot orthosis, spiral, (institute of rehabilitative medicine type), plastic or other material, prefabricated, off-the-shelf


name: Endoskeletal knee-shin system, single axis, electromechanical swing and stance phase control, with or without shock absorption and stance extension damping


name: Partial hand, finger, and thumb prosthesis without prosthetic digit(s)/thumb, amputation at metacarpal level, including flexible or non-flexible interface, molded to patient model, including palm, for use without external power and/or passive prosthetic digit/thumb, not including inserts described by l6692


name: Upper extremity addition, test socket/interface, partial hand including fingers


name: Upper extremity addition, external frame, partial hand including fingers


name: Replacement socket/interface, partial hand including fingers, molded to patient model, for use with or without external power


name: Addition to upper extremity prosthesis, partial hand including fingers, ultralight material (titanium, carbon fiber or equal)


name: Addition to upper extremity prosthesis, partial hand including fingers, acrylic material


name: Immediate post-surgical or early fitting, application of initial rigid dressing, including fitting alignment and suspension of components, and one cast change, partial hand including fingers


name: Addition to upper extremity prosthesis, lock mechanism, excludes socket insert


name: Upper extremity addition, external powered feature, myoelectronic control module, additional emg inputs, pattern-recognition decoding intent movement


name: Addition to upper extremity prosthesis, user adjustable, mechanical, residual limb volume management system (with or without lamination kit)


name: Palingen dual-layer membrane and dual-layer palingen x-membrane, per square centimeter (add-on, list separately in addition to primary procedure)


name: Abiomend xplus membrane and abiomend xplus hydromembrane, per square centimeter (add-on, list separately in addition to primary procedure)


name: Abiomend membrane and abiomend hydromembrane, per square centimeter (add-on, list separately in addition to primary procedure)


name: Xwrap plus, per square centimeter (add-on, list separately in addition to primary procedure)


name: Xwrap dual, per square centimeter (add-on, list separately in addition to primary procedure)


name: Choriply, per square centimeter (add-on, list separately in addition to primary procedure)


name: Amchoplast fd, per square centimeter (add-on, list separately in addition to primary procedure)


name: Epixpress, per square centimeter (add-on, list separately in addition to primary procedure)


name: Cygnus disk, per square centimeter (add-on, list separately in addition to primary procedure)


name: Amnio burgeon membrane and hydromembrane, per square centimeter (add-on, list separately in addition to primary procedure)


name: Amnio burgeon xplus membrane and xplus hydromembrane, per square centimeter (add-on, list separately in addition to primary procedure)


name: Amnio burgeon dual-layer membrane, per square centimeter (add-on, list separately in addition to primary procedure)


name: Dual layer amnio burgeon x-membrane, per square centimeter (add-on, list separately in addition to primary procedure)


name: Amniocore sl, per square centimeter (add-on, list separately in addition to primary procedure)


name: Air polymer-type a intrauterine foam, per study dose


name: Infectious disease (acid-fast bacteria and invasive fungi), DNA (673 organisms), next-generation sequencing, plasma


name: Rare diseases (constitutional disease/hereditary disorders), rapid whole genome and mitochondrial DNA sequencing for single-nucleotide variants, insertions/deletions, copy number variations, peripheral blood, buffy coat, saliva, buccal or tissue sample, results reported as positive or negative


name: Drug metabolism (adverse drug reactions and drug response), genotyping of 16 genes (ie, ABCG2, CYP2B6, CYP2C9, CYP2C19, CYP2C, CYP2D6, CYP3A5, CYP4F2, DPYD, G6PD, GGCX, NUDT15, SLCO1B1, TPMT, UGT1A1, VKORC1), reported as metabolizer status and transporter function


name: Oncology (prostate), microRNA, single-nucleotide polymorphisms (SNPs) analysis by RT-PCR of 32 variants, using buccal swab, algorithm reported as a risk score


name: Perfluoroalkyl substances (PFAS) (eg, perfluorooctanoic acid, perfluorooctane sulfonic acid), by liquid chromatography with tandem mass spectrometry (LC-MS/MS), plasma or serum, quantitative


name: Red blood cell antigen (fetal RhD), PCR analysis of exon 4 of RHD gene and housekeeping control gene GAPDH from whole blood in pregnant individuals at 10+ weeks gestation known to be RhD negative, reported as fetal RhD status


name: Oncology (colorectal cancer), analysis of cell-free DNA for epigenomic patterns, next-generation sequencing, >2,500 differentially methylated regions (DMRs), plasma, algorithm reported as positive or negative


name: Oncology (solid tumor), next-generation targeted sequencing analysis, formalin-fixed paraffin-embedded (FFPE) tumor tissue, DNA analysis of 600 genes, interrogation for single-nucleotide variants, insertions/deletions, gene rearrangements, and copy number alterations, microsatellite instability, tumor mutation burden, reported as actionable variant


name: Oncology (solid tumor), cell-free circulating tumor DNA (ctDNA), 152 genes, next-generation sequencing, interrogation for single-nucleotide variants, insertions/deletions, gene rearrangements, copy number alterations, and microsatellite instability, using whole-blood samples, mutations with clinical actionability reported as actionable variant


name: Transplantation medicine, quantification of donor-derived cell-free DNA using next-generation sequencing analysis of plasma, reported as percentage of donor-derived cell-free DNA to determine probability of rejection


name: Cardiovascular disease (HDL reverse cholesterol transport), cholesterol efflux capacity, LC-MS/MS, quantitative measurement of 5 distinct HDL-bound apolipoproteins (apolipoproteins A1, C1, C2, C3, and C4), serum, algorithm reported as prediction of coronary artery disease (pCAD) score


name: Nephrology (renal transplant), urine, nuclear magnetic resonance (NMR) spectroscopy measurement of 84 urinary metabolites, combined with patient data, quantification of BK virus (human polyomavirus 1) using real-time PCR and serum creatinine, algorithm reported as a probability score for allograft injury status


name: Oncology (solid tumor), next-generation sequencing of DNA from formalin-fixed paraffin-embedded (FFPE) tissue of 517 genes, interrogation for single-nucleotide variants, multi-nucleotide variants, insertions and deletions from DNA, fusions in 24 genes and splice variants in 1 gene from RNA, and tumor mutation burden


name: Nephrology (transplant monitoring), 48 variants by digital PCR, using cell-free DNA from plasma, donor-derived cell-free DNA, percentage reported as risk for rejection


name: Acetylcholine receptor (AChR), antibody identification by immunofluorescence, using live cells, reported as positive or negative


name: Low-density lipoprotein receptor-related protein 4 (LRP4), antibody identification by immunofluorescence, using live cells, reported as positive or negative


name: Neurofilament light chain (NfL), chemiluminescent enzyme immunoassay, plasma, quantitative


name: Glial fibrillary acidic protein (GFAP), chemiluminescent enzyme immunoassay, using plasma


name: Oncology (urothelial), DNA, quantitative methylated real-time PCR of TRNA-Cys, SIM2, and NKX1-1, using urine, diagnostic algorithm reported as a probability index for bladder cancer and/or upper tract urothelial carcinoma (UTUC)


name: Oncology (prostate), enzyme-linked immunosorbent assays (ELISA) for total prostate-specific antigen (PSA) and free PSA, serum, combined with age, previous negative prostate biopsy status, digital rectal examination findings, prostate volume, and image and data reporting of the prostate, algorithm reported as a risk score for the presence of high-grade prostate cancer


name: Tau, phosphorylated, pTau217, by single-molecule array (ultrasensitive digital protein detection), using plasma


name: Established patient office or other outpatient visit with low level of decision making, if using time, 20 minutes or more


name: Subsequent hospital inpatient or observation care with moderate level of medical decision making, if using time, 35 minutes or more


name: Sepsis-related Organ Failure Assessment 27th March 2024 Version Clinical Classification


name: Autologous Genome-Edited Hematopoietic Stem-Cell-Based Gene Therapy [EPC]


name: Oligonucleotide Telomerase Inhibitor [EPC]


name: Melanoma-associated Antigen A4-directed Genetically Modified Autologous T Cell Immunotherapy [EPC]


name: Thyroid Hormone Receptor beta Agonist [EPC]


name: Peroxisome Proliferator-activated Receptor Agonist [EPC]


name: Peroxisome Proliferator Receptor delta Agonist [EPC]


name: CXC Chemokine Receptor 4 Antagonist [EPC]


name: Interleukin-31 Receptor alpha Antagonist [EPC]


name: Colony Stimulating Factor-1 Receptor Blocker [EPC]


name: Impaired function of musculoskeletal system


name: extracorporeal ventricular assist device implantation


name: Destruction of trigeminal ganglion by radiofrequency


name: blood hemoglobin A1C measurement (lab test)


name: Drainage of abscess of eyelid (procedure)


name: Combined anteroposterior colporrhaphy for repair of cystocele and rectocele


name: Screening for harmful pattern of substance use


name: Reconstruction of external auditory canal (procedure)


name: Proton Magnetic Resonance Spectroscopic Imaging


name: Chuloonawick Native Village, Tribal Entity


name: Native Village of Hamilton, Tribal Entity


name: Native Village of Kanatak, Tribal Entity


name: King Island Native Community, Tribal Entity


name: Native Village of Paimiut, Tribal Entity


name: Native Village of Venetie Tribal Government, Tribal Entity


name: Alturas Indian Rancheria, California, Tribal Entity


name: Big Lagoon Rancheria, California, Tribal Entity


name: Blue Lake Rancheria, California, Tribal Entity


name: Cloverdale Rancheria of Pomo Indians of California, Tribal Entity


name: Coushatta Tribe of Louisiana, Tribal Entity


name: Coyote Valley Band of Pomo Indians of California, Tribal Entity


name: Elk Valley Rancheria, California, Tribal Entity


name: Guidiville Rancheria of California, Tribal Entity


name: Ione Band of Miwok Indians of California, Tribal Entity


name: Jamul Indian Village of California, Tribal Entity


name: Little River Band of Ottawa Indians, Michigan, Tribal Entity


name: Lytton Rancheria of California, Tribal Entity


name: Middletown Rancheria of Pomo Indians of California, Tribal Entity


name: Mooretown Rancheria of Maidu Indians of California, Tribal Entity


name: Northfork Rancheria of Mono Indians of California, Tribal Entity


name: Pueblo of Zia, New Mexico, Tribal Entity


name: Redding Rancheria, California, Tribal Entity


name: Imaging guided percutaneous transluminal angioplasty of blood vessel with contrast


name: extracorporeal ventricular assist device removal


name: My voice difficulties restrict my personal and social life


name: The clarity of my voice is unpredictable


name: I feel as though I have to strain to produce voice


name: I feel left out of conversations because of my voice


name: inhibition of host BST2/Tetherin by virus


name: sacubitril and valsartan sodium hydrate drug combination


name: My voice problem causes me to lose income


name: Peanut Allergen-dnfp;Peanut Allergen-dnfp 0.5 MG; 1 MG Oral Capsule [Palforzia Initial Dose Escalation]


name: Nirmatrelvir;Ritonavir 150 MG; 100 MG Oral Tablet [PAXLOVID 300MG;100MG DOSE PACK]


name: Hopland Band of Pomo Indians, California, Tribal Entity


name: Houlton Band of Maliseet Indians, Tribal Entity


name: Jackson Band of Miwuk Indians, Tribal Entity


name: Kickapoo Tribe of Indians of the Kickapoo Reservation in Kansas, Tribal Entity


name: Bay Mills Indian Community, Michigan, Tribal Entity


name: Little Traverse Bay Bands of Odawa Indians, Michigan, Tribal Entity


name: Koi Nation of Northern California, Tribal Entity


name: Manchester Band of Pomo Indians of the Manchester Rancheria, California, Tribal Entity


name: Berry Creek Rancheria of Maidu Indians of California, Tribal Entity


name: Match-e-be-nash-she-wish Band of Pottawatomi Indians of Michigan, Tribal Entity


name: Mechoopda Indian Tribe of Chico Rancheria, California, Tribal Entity


name: Big Sandy Rancheria of Western Mono Indians of California, Tribal Entity


name: Big Valley Band of Pomo Indians of the Big Valley Rancheria, California, Tribal Entity


name: Blackfeet Tribe of the Blackfeet Indian Reservation of Montana, Tribal Entity


name: Potter Valley Tribe, California, Tribal Entity


name: Buena Vista Rancheria of Me-Wuk Indians of California, Tribal Entity


name: Quartz Valley Indian Community of the Quartz Valley Reservation of California, Tribal Entity


name: Ramona Band of Cahuilla, California, Tribal Entity


name: Redwood Valley or Little River Band of Pomo Indians of the Redwood Valley Rancheria California, Tribal Entity


name: Rincon Band of Luiseno Mission Indians of Rincon Reservation, California, Tribal Entity


name: Yocha Dehe Wintun Nation, California, Tribal Entity


name: Cachil DeHe Band of Wintun Indians of the Colusa Indian Community of the Colusa Rancheria, California, Tribal Entity


name: Sherwood Valley Rancheria of Pomo Indians of California, Tribal Entity


name: Southern Ute Indian Tribe of the Southern Ute Reservation, Colorado, Tribal Entity


name: California Valley Miwok Tribe, California, Tribal Entity


name: Tuolumne Band of Me-Wuk Indians of the Tuolumne Rancheria of California, Tribal Entity


name: United Auburn Indian Community of the Auburn Rancheria of California, Tribal Entity


name: United Keetoowah Band of Cherokee Indians in Oklahoma, Tribal Entity


name: Habematolel Pomo of Upper Lake, California, Tribal Entity


name: Native Village of Afognak, Tribal Entity


name: Native Village of Atqasuk, Tribal Entity


name: Cher-Ae Heights Indian Community of the Trinidad Rancheria, California, Tribal Entity


name: Chicken Ranch Rancheria of Me-Wuk Indians of California, Tribal Entity


name: Cold Springs Rancheria of Mono Indians of California, Tribal Entity


name: Central Council of the Tlingit and Haida Indian Tribes, Tribal Entity


name: Wilton Rancheria, California, Tribal Entity


name: Delaware Nation, Oklahoma, Tribal Entity


name: Enterprise Rancheria of Maidu Indians of California, Tribal Entity


name: Fort McDowell Yavapai Nation, Arizona, Tribal Entity


name: Grindstone Indian Rancheria of Wintun-Wailaki Indians of California, Tribal Entity


name: {16 (selinexor 10 MG Oral Tablet [Xpovio]) } Pack [Xpovio 40 MG Once Weekly Carton-10 MG Tablet]


name: Date tumor specimen received in laboratory:Date:Pt:^Patient:Qn


name: Decreased mobility due to loss of weight:Find:Pt:^Patient:Ord


name: Decreased mobility due to loss of weight


name: Date tumor specimen received in laboratory


name: Anterior Vagina Maximum Prolapse Quantification


name: Is this for a prosthetic joint:Find:Pt:^Patient:Ord


name: utility disconnect notice due to inability to pay


name: White River Band of the Chickamauga-Cherokee


name: Encounter due to utility disconnect notice due to inability to pay


name: Number of stairs to enter home:Num:Pt:^Patient:Qn


name: The Modoc Tribe of Oklahoma (ethnic group)


name: Number of stairs within home:Num:Pt:^Patient:Qn


name: Rate your overall mood during the past week


name: Rate your overall mood during the past week:Find:Pt:^Patient:Ord


name: Rate your pain level at the present moment


name: Rate your pain level at the present moment:Find:Pt:^Patient:Ord


name: Encourages me to work on a hobby:Find:Pt:^Patient:Ord


name: Triazaacenaphthylene Bacterial Type II Topoisomerase Inhibitor [EPC]


name: Other specified abnormal immunological findings in serum (R76.89)


name: Since you speak a language other than English at home, we are interested in your own opinion of how well you speak English. Would you say you speak English


name: Encounter due to personal risk factor of exposure to diethylstilbestrol


name: personal risk factor of exposure to diethylstilbestrol


name: Since you speak a language other than English at home, we are interested in your own opinion of how well you speak English. Would you say you speak English:Find:Pt:^Patient:Ord


name: Allogeneic Dermal Fibroblast Cell Therapy [EPC]


name: {6 (iloperidone 1 MG Oral Tablet [Fanapt]) / 2 (iloperidone 2 MG Oral Tablet [Fanapt]) / 2 (iloperidone 6 MG Oral Tablet [Fanapt]) / 2 (iloperidone 8 MG Oral Tablet [Fanapt]) } Pack [Fanapt Titration Pack B]


name: Antithrombin-directed RNA Interaction [EPC]


name: Allogeneic Epidermal Keratinocyte Cell Therapy [EPC]


name: Respiratory Syncytial Virus mRNA Vaccine [EPC]


name: Posterior Vagina Maximum Prolapse Quantification


name: Cervix or Vaginal Cuff Strain Quantification


name: Upper limb amputation above the elbow (procedure)


name: Upper limb amputation below the elbow (procedure)


name: Hepatitis B virus core Ab:{Measurement}:-:Ser^Donor:-


name: Hepatitis B virus core Ab:{Measurement}:-:Ser:-


name: Substance with sphingosine 1-phosphate receptor antagonist mechanism of action


name: Sphingosine 1-phosphate receptor antagonist (disposition)


name: Horowitz & adjusted|BLDA+Inhaled gas (LG51998-9)


name: Horowitz & adjusted|BLDA+Inhaled gas (LG52051-6)


name: How attentive is your significant other to your pain problem


name: How attentive is your significant other to your pain problem:Find:Pt:^Patient:Ord


name: How irritable have you been during the past week


name: How irritable have you been during the past week:Find:Pt:^Patient:Ord


name: How much control do you feel that you have had over your life during the past week:Find:Pt:^Patient:Ord


name: How much control do you feel that you have had over your life during the past week


name: How much do you feel you've been able to deal with your problems during the past week


name: How much do you feel you've been able to deal with your problems during the past week:Find:Pt:^Patient:Ord


name: How much does your pain interfere with your daily activities:Find:Pt:^Patient:Ord


name: Increased eosinophil count of ascitic fluid


name: Pulmonary rehabilitation exercise training


name: CD33 Expression 50 Percent or More of Neoplastic Cells


name: Autologous Chondrocyte Cell Therapy [EPC]


name: Substance with cardiac myosin inhibitor mechanism of action


name: Coagulation Surface Induced|Pt|ANYBldPPP (LG52001-1)


name: Coagulation Surface Induced|Pt|ANYBldPPP (LG52054-0)


name: The food we bought just didn't last and we didn't have money to get more


name: The food we bought just didn't last and we didn't have money to get more:Find:12Mo:^Patient:Ord


name: Autologous Fibroblast Cell Therapy [EPC]


name: Tries to get me to rest:Find:Pt:^Patient:Ord


name: Tries to involve me in some activity:Find:Pt:^Patient:Ord


name: Troponin I.cardiac high sensitivity|MCncORImp|Pt|ANYBldSerPl (LG51995-5)


name: Troponin I.cardiac high sensitivity|MCncORImp|Pt|ANYBldSerPl (LG51991-4)


name: Turns on the TV to take my mind off my pain


name: Turns on the TV to take my mind off my pain:Find:Pt:^Patient:Ord


name: Expresses anger at me:Find:Pt:^Patient:Ord


name: Hypereosinophilia level indicating malignancy


name: Expresses frustration at me:Find:Pt:^Patient:Ord


name: Expresses irritation at me:Find:Pt:^Patient:Ord


name: Complement C3 & C4 & C1q Ab.IgG panel:-:Pt:Ser/Plas:-


name: Relevant diagnostic tests &or laboratory data note


name: Differential diagnosis (observable entity)


name: Increased eosinophil count of gastrointestinal tract


name: Lymphocyte proliferation.concanavalin A stimulation:ACnc:Pt:Bld:Qn


name: Lymphocyte proliferation.Candida albicans stimulation:NRat:Pt:Bld:Qn


name: Living accommodation heating system:Type:Pt:^Patient:Nom


name: allergy to eggs with reactivity to baked egg


name: Encounter due to allergy to eggs with reactivity to baked egg


name: Encounter due to allergy to eggs with tolerance to baked egg


name: allergy to eggs with tolerance to baked egg


name: Encounter due to allergy to milk products with reactivity to baked milk


name: allergy to milk products with reactivity to baked milk


name: allergy to milk products with tolerance to baked milk


name: Encounter due to allergy to milk products with tolerance to baked milk


name: How much does your pain interfere with your daily activities


name: How much has your pain changed your ability to do household chores:Find:Pt:^Patient:Ord


name: How much has your pain changed your ability to do household chores


name: How much has your pain changed your ability to participate in recreational and other social activities:Find:Pt:^Patient:Ord


name: How much has your pain changed your ability to participate in recreational and other social activities


name: How much has your pain changed your ability to work:Find:Pt:^Patient:Ord


name: How much has your pain changed your ability to work


name: How much has your pain changed your friendships with people other than your family:Find:Pt:^Patient:Ord


name: How much has your pain changed your friendships with people other than your family


name: How much has your pain changed your marriage and other family relationships:Find:Pt:^Patient:Ord


name: How much has your pain changed your marriage and other family relationships


name: How much has your pain changed your satisfaction from family-related activities


name: Building Capacity within the NCORP Network through an Education and Mentorship Intervention


name: Hester Davis scale total score:Score:Pt:^Patient:Qn


name: {5 (3.8 ML remestemcel-L-rknd 6680000 CELLS/ML Injection [Ryoncil]) } Pack [Ryoncil Kit 50 - < 62.5 kg]


name: {6 (3.8 ML remestemcel-L-rknd 6680000 CELLS/ML Injection [Ryoncil]) } Pack [Ryoncil Kit 62.5 - < 75 kg]


name: {8 (3.8 ML remestemcel-L-rknd 6680000 CELLS/ML Injection [Ryoncil]) } Pack [Ryoncil Kit 87.5 - < 100 kg]


name: {3 (3.8 ML remestemcel-L-rknd 6680000 CELLS/ML Injection [Ryoncil]) } Pack [Ryoncil Kit 25 - < 37.5 kg]


name: {2 (3.8 ML remestemcel-L-rknd 6680000 CELLS/ML Injection [Ryoncil]) } Pack [Ryoncil Kit 12.5 - < 25 kg]


name: {4 (3.8 ML remestemcel-L-rknd 6680000 CELLS/ML Injection [Ryoncil]) } Pack [Ryoncil Kit 37.5 - < 50 kg]


name: {1 (3.8 ML remestemcel-L-rknd 6680000 CELLS/ML Injection [Ryoncil]) } Pack [Ryoncil Kit < 12.5 kg]


name: {7 (3.8 ML remestemcel-L-rknd 6680000 CELLS/ML Injection [Ryoncil]) } Pack [Ryoncil Kit 75 - < 87.5 kg]


name: Encounter due to genetic susceptibility to colorectal cancer


name: genetic susceptibility to colorectal cancer


name: genetic susceptibility to kidney disease


name: Encounter due to genetic susceptibility to kidney disease


name: genetic susceptibility to malignant neoplasm of digestive system


name: Encounter due to genetic susceptibility to malignant neoplasm of digestive system


name: Encounter due to genetic susceptibility to malignant neoplasm of urinary tract


name: genetic susceptibility to malignant neoplasm of urinary tract


name: genetic susceptibility to other malignant neoplasm of digestive system


name: Encounter due to genetic susceptibility to other malignant neoplasm of digestive system


name: How much has your pain changed your satisfaction from family-related activities:Find:Pt:^Patient:Ord


name: How much has your pain changed your satisfaction from social and recreational activities


name: How much has your pain changed your satisfaction from social and recreational activities:Find:Pt:^Patient:Ord


name: How much has your pain changed your satisfaction from work


name: How much has your pain changed your satisfaction from work:Find:Pt:^Patient:Ord


name: How much suffering do you experience because of your pain:Find:Pt:^Patient:Ord


name: How much suffering do you experience because of your pain


name: How often did you cut the size of your meals or skip meals because there wasn't enough money for food:Find:12Mo:^Patient:Ord


name: How often did you cut the size of your meals or skip meals because there wasn't enough money for food


name: How severe has your pain been during the last week


name: How severe has your pain been during the last week:Find:Pt:^Patient:Ord


name: How supportive is your significant other in relation to your pain:Find:Pt:^Patient:Ord


name: How supportive is your significant other in relation to your pain


name: Neonatal fragment crystallizable receptor antagonist (disposition)


name: Substance with neonatal fragment crystallizable receptor antagonist mechanism of action


name: How tense or anxious have you been during the past week


name: How tense or anxious have you been during the past week:Find:Pt:^Patient:Ord


name: Non-specific serine threonine protein kinase inhibitor (disposition)


name: Substance with non-specific serine threonine protein kinase inhibitor mechanism of action


name: How worried is your significant other about you in relation to your pain problem


name: How worried is your significant other about you in relation to your pain problem:Find:Pt:^Patient:Ord


name: I can tell high quality health resources from low quality health resources on the Internet:Find:Pt:^Patient:Ord


name: I can tell high quality health resources from low quality health resources on the Internet


name: I feel confident in using information from the Internet to make health decisions:Find:Pt:^Patient:Ord


name: Asks me what they can do to help:Find:Pt:^Patient:Ord


name: Myositis specific Ab panel:-:Pt:Ser/Plas:-


name: Patient on room air:Find:Pt:^Patient:Nom


name: Participation in society note:Find:Pt:^Patient:Doc


name: Play cards or other games:Find:Pt:^Patient:Ord


name: Pre-Procedure Thyroid Hormone Therapy Withdrawal


name: I have the skills I need to evaluate the health resources I find on the Internet:Find:Pt:^Patient:Ord


name: I feel confident in using information from the Internet to make health decisions


name: I have the skills I need to evaluate the health resources I find on the Internet